(+)-catechin decreases activity EXP 6480464 Catechin results in decreased activity of CYP19A1 protein CTD PMID:18534843 (-)-epigallocatechin 3-gallate decreases activity ISO RGD:737520 6480464 epigallocatechin gallate results in decreased activity of CYP19A1 protein CTD PMID:14600287 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [lead acetate results in decreased expression of CYP19A1 mRNA] CTD PMID:31054310 (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of CYP19A1 mRNA CTD PMID:31054310 (E)-thiamethoxam increases expression ISO RGD:1606587 6480464 Thiamethoxam results in increased expression of CYP19A1 mRNA CTD PMID:26464060 (E)-thiamethoxam multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of CYP19A1 mRNA] CTD PMID:34181816 (E)-thiamethoxam increases expression EXP 6480464 Thiamethoxam results in increased expression of CYP19A1 mRNA CTD PMID:34181816 (E)-thiamethoxam increases activity ISO RGD:1606587 6480464 Thiamethoxam results in increased activity of CYP19A1 protein CTD PMID:26464060 , PMID:28750898 (S)-naringenin multiple interactions ISO RGD:1606587 6480464 naringenin binds to and results in decreased activity of CYP19A1 protein CTD PMID:9435150 (S)-naringenin decreases activity EXP 6480464 naringenin results in decreased activity of CYP19A1 protein CTD PMID:17895526 (S)-naringenin decreases activity ISO RGD:1606587 6480464 naringenin results in decreased activity of CYP19A1 protein CTD PMID:15319488 (S)-nicotine decreases expression ISO RGD:1606587 6480464 Nicotine results in decreased expression of CYP19A1 mRNA, Nicotine results in decreased expression of CYP19A1 protein CTD PMID:30959089 (S)-nicotine increases activity ISO RGD:1606587 6480464 Nicotine results in increased activity of CYP19A1 protein CTD PMID:32113805 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of CYP19A1 mRNA, Nicotine results in decreased expression of CYP19A1 protein CTD PMID:30959089 (S)-nicotine multiple interactions ISO RGD:1606587 6480464 Vecuronium Bromide inhibits the reaction [Nicotine results in decreased expression of CYP19A1 mRNA], Vecuronium Bromide inhibits the reaction [Nicotine results in decreased expression of CYP19A1 protein] CTD PMID:30959089 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions ISO RGD:1606587 6480464 2 more ... CTD PMID:22120136 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:16737795 , PMID:19414516 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases expression EXP 6480464 2 more ... CTD PMID:22120136 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases activity EXP 6480464 2 more ... CTD PMID:22120136 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases expression ISO RGD:1606587 6480464 2 more ... CTD PMID:22120136 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane decreases expression ISO RGD:737520 6480464 1 more ... CTD PMID:20840852 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:1606587 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [o more ... CTD PMID:17599374 , PMID:20678559 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:737520 6480464 o, p'-DDT results in decreased expression of CYP19A1 mRNA CTD PMID:28263910 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases activity ISO RGD:1606587 6480464 o, p'-DDT results in decreased activity of CYP19A1 protein CTD PMID:17599374 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1606587 6480464 o more ... CTD PMID:20678559 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile decreases activity ISO RGD:1606587 6480464 Citalopram results in decreased activity of CYP19A1 protein CTD PMID:26162595 1-benzofuran decreases activity ISO RGD:1606587 6480464 benzofuran analog results in decreased activity of CYP19A1 protein CTD PMID:15968818 1-naphthylamine increases expression ISO RGD:1606587 6480464 1-Naphthylamine results in increased expression of CYP19A1 mRNA CTD PMID:31100596 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CYP19A1 mRNA, Ethinyl Estradiol results in increased expression of CYP19A1 protein CTD PMID:28522409 17beta-estradiol increases expression ISO RGD:1606587 6480464 Estradiol results in increased expression of CYP19A1 mRNA more ... CTD PMID:16029874 , PMID:18462857 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP19A1 mRNA CTD PMID:36931579 17beta-estradiol increases expression ISO RGD:737520 6480464 Estradiol results in increased expression of CYP19A1 mRNA CTD PMID:30196065 17beta-estradiol increases abundance ISO RGD:1606587 6480464 CYP19A1 protein results in increased abundance of Estradiol CTD PMID:31374317 17beta-estradiol decreases expression ISO RGD:1606587 6480464 Estradiol results in decreased expression of CYP19A1 mRNA CTD PMID:26921789 , PMID:31646340 17beta-estradiol increases activity ISO RGD:1606587 6480464 Estradiol results in increased activity of CYP19A1 protein CTD PMID:12839940 , PMID:15955695 17beta-estradiol affects chemical synthesis ISO RGD:1606587 6480464 CYP19A1 protein affects the chemical synthesis of Estradiol CTD PMID:16024248 , PMID:16030167 17beta-estradiol affects expression ISO RGD:1606587 6480464 Estradiol affects the expression of CYP19A1 mRNA CTD PMID:14699072 17beta-estradiol increases chemical synthesis ISO RGD:1606587 6480464 CYP19A1 protein results in increased chemical synthesis of Estradiol CTD PMID:16054388 , PMID:32197950 17beta-estradiol multiple interactions ISO RGD:1606587 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased activity of CYP19A1 protein] more ... CTD PMID:12839940 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP19A1 mRNA CTD PMID:18191889 17beta-estradiol affects activity EXP 6480464 Estradiol affects the activity of CYP19A1 protein CTD PMID:21068160 17beta-estradiol increases chemical synthesis EXP 6480464 CYP19A1 protein results in increased chemical synthesis of Estradiol CTD PMID:16569475 , PMID:21259292 17beta-estradiol multiple interactions EXP 6480464 [Androstenedione results in decreased expression of CYP19A1 mRNA] which results in decreased abundance of Estradiol more ... CTD PMID:18191889 more ... 17beta-estradiol multiple interactions ISO RGD:737520 6480464 [[NR5A2 protein results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in decreased activity of CYP19A1 protein] which results in decreased chemical synthesis of Estradiol more ... CTD PMID:11985600 , PMID:18628394 17beta-estradiol 3-benzoate affects response to substance ISO RGD:737520 6480464 CYP19A1 protein affects the susceptibility to estradiol 3-benzoate CTD PMID:16884724 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of CYP19A1 mRNA, Dihydrotestosterone results in increased expression of CYP19A1 protein CTD PMID:15525594 , PMID:21273442 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of CYP19A1 mRNA, Dihydrotestosterone results in decreased expression of CYP19A1 protein CTD PMID:22948218 17beta-hydroxy-5alpha-androstan-3-one multiple interactions EXP 6480464 FSHB protein inhibits the reaction [Dihydrotestosterone results in decreased expression of CYP19A1 protein] CTD PMID:22948218 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:1606587 6480464 2 more ... CTD PMID:22262711 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1606587 6480464 [bisphenol A co-treated with 2 more ... CTD PMID:25765474 , PMID:34929288 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:1606587 6480464 2 more ... CTD PMID:22262711 2,2',4,4'-Tetrabromodiphenyl ether decreases activity ISO RGD:1606587 6480464 2 more ... CTD PMID:16177243 , PMID:18022659 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:1606587 6480464 [Tetrachlorodibenzodioxin co-treated with 3 more ... CTD PMID:25765474 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1606587 6480464 2 more ... CTD PMID:18248924 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1606587 6480464 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA] more ... CTD PMID:19147701 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737520 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA CTD PMID:22889882 , PMID:24793433 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1606587 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA, Tetrachlorodibenzodioxin results in increased expression of CYP19A1 protein CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA CTD PMID:11026553 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1606587 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA, Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 protein CTD PMID:20823264 , PMID:25697571 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA CTD PMID:15590112 2,3,7,8-tetrachlorodibenzodioxine decreases activity EXP 6480464 Tetrachlorodibenzodioxin results in decreased activity of CYP19A1 protein CTD PMID:16141434 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Gonadotropins more ... CTD PMID:11026553 , PMID:19276399 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP19A1 mRNA, Tetrachlorodibenzodioxin affects the expression of CYP19A1 protein CTD PMID:18284931 2,3,7,8-tetrachlorodibenzodioxine increases stability ISO RGD:1606587 6480464 Tetrachlorodibenzodioxin results in increased stability of CYP19A1 mRNA CTD PMID:19962423 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:1606587 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP19A1 protein CTD PMID:19962423 2,3,7,8-tetrachlorodibenzodioxine affects activity ISO RGD:1606587 6480464 Tetrachlorodibenzodioxin affects the activity of CYP19A1 protein CTD PMID:12916318 2,3-Bis(3-hydroxybenzyl)butane-1,4-diol decreases activity ISO RGD:1606587 6480464 2 more ... CTD PMID:15876411 2,4,6-tribromophenol increases expression ISO RGD:1606587 6480464 2 more ... CTD PMID:17447562 2,4,6-tribromophenol increases activity ISO RGD:1606587 6480464 2 more ... CTD PMID:16177243 2,4,6-trichlorophenol decreases expression ISO RGD:1606587 6480464 2 more ... CTD PMID:21296122 2,4-dibromophenol increases expression ISO RGD:1606587 6480464 2, 4-dibromophenol results in increased expression of CYP19A1 mRNA CTD PMID:17447562 2-bromophenol increases expression ISO RGD:1606587 6480464 2-bromophenol results in increased expression of CYP19A1 mRNA CTD PMID:17447562 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine affects chemical synthesis ISO RGD:1606587 6480464 CYP19A1 protein affects the chemical synthesis of 2-ethylidene-1 more ... CTD PMID:15242824 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine multiple interactions ISO RGD:1606587 6480464 Aminoglutethimide inhibits the reaction [CYP19A1 protein affects the chemical synthesis of 2-ethylidene-1 more ... CTD PMID:15242824 3',5'-cyclic AMP multiple interactions ISO RGD:1606587 6480464 [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of CYP19A1 mRNA more ... CTD PMID:31953017 3',5'-cyclic AMP increases expression ISO RGD:1606587 6480464 Cyclic AMP results in increased expression of CYP19A1 mRNA, Cyclic AMP results in increased expression of CYP19A1 protein CTD PMID:29228121 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1606587 6480464 [Tetrachlorodibenzodioxin co-treated with 3 more ... CTD PMID:25765474 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1606587 6480464 3 more ... CTD PMID:16216300 more ... 3,3',5,5'-tetrabromobisphenol A decreases activity ISO RGD:1606587 6480464 tetrabromobisphenol A analog results in decreased activity of CYP19A1 protein CTD PMID:16177243 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1606587 6480464 tetrabromobisphenol A results in increased expression of CYP19A1 protein CTD PMID:25223798 3,3'-diindolylmethane increases expression ISO RGD:1606587 6480464 3 more ... CTD PMID:11294972 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol increases expression ISO RGD:1606587 6480464 fluorotelomer alcohols results in increased expression of CYP19A1 mRNA CTD PMID:23142464 3,4-dichloroaniline increases expression ISO RGD:1606587 6480464 3, 4-dichloroaniline results in increased expression of CYP19A1 mRNA CTD PMID:31100596 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1606587 6480464 1-Methyl-3-isobutylxanthine inhibits the reaction [Atrazine inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA]], 1-Methyl-3-isobutylxanthine inhibits the reaction [T-2 Toxin inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA]] CTD PMID:28859905 , PMID:30951242 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1606587 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of CYP19A1 mRNA CTD PMID:31100596 4,4'-sulfonyldiphenol increases expression ISO RGD:737520 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CYP19A1 mRNA CTD PMID:29741722 , PMID:30196065 4,4'-sulfonyldiphenol increases activity ISO RGD:1606587 6480464 bis(4-hydroxyphenyl)sulfone results in increased activity of CYP19A1 protein CTD PMID:30817981 4,4'-sulfonyldiphenol increases expression ISO RGD:1606587 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CYP19A1 mRNA CTD PMID:30817981 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile multiple interactions ISO RGD:1606587 6480464 Genistein inhibits the reaction [Fadrozole results in increased activity of CYP19A1 protein] CTD PMID:21854827 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile increases activity ISO RGD:1606587 6480464 Fadrozole results in increased activity of CYP19A1 protein CTD PMID:21854827 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile decreases activity ISO RGD:1606587 6480464 Fadrozole results in decreased activity of CYP19A1 protein CTD PMID:15743198 more ... 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:1606587 6480464 Am 580 results in increased expression of CYP19A1 mRNA CTD PMID:15941851 4-Hydroxy-N-desmethyltamoxifen increases metabolic processing ISO RGD:1606587 6480464 CYP19A1 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen CTD PMID:29285606 4-Hydroxy-N-desmethyltamoxifen multiple interactions ISO RGD:1606587 6480464 [CYP19A1 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen] which results in increased abundance of 4-hydroxy-N-desmethyltamoxifen metabolite CTD PMID:29285606 4-nitrophenol decreases expression EXP 6480464 4-nitrophenol results in decreased expression of CYP19A1 mRNA CTD PMID:24070737 4-nonylphenol multiple interactions ISO RGD:737520 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 mRNA, [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 protein CTD PMID:29029336 4-nonylphenol decreases expression ISO RGD:737520 6480464 4-nonylphenol results in decreased expression of CYP19A1 mRNA, 4-nonylphenol results in decreased expression of CYP19A1 protein CTD PMID:29029336 4-tert-Octylphenol multiple interactions ISO RGD:737520 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 mRNA, [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 protein CTD PMID:29029336 4-tert-Octylphenol decreases expression ISO RGD:737520 6480464 4-tert-octylphenol results in decreased expression of CYP19A1 mRNA CTD PMID:29029336 5-aza-2'-deoxycytidine affects methylation ISO RGD:1606587 6480464 Decitabine affects the methylation of CYP19A1 promoter CTD PMID:17662285 6-propyl-2-thiouracil decreases expression ISO RGD:737520 6480464 Propylthiouracil results in decreased expression of CYP19A1 mRNA CTD PMID:36706583 7-hydroxyflavanone decreases activity ISO RGD:1606587 6480464 7-hydroxyflavanone results in decreased activity of CYP19A1 protein CTD PMID:15319488 7-hydroxyflavone decreases activity ISO RGD:1606587 6480464 7-hydroxyflavone results in decreased activity of CYP19A1 protein CTD PMID:15319488 8-Br-cAMP multiple interactions EXP 6480464 [vinclozolin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP19A1 mRNA more ... CTD PMID:22120136 , PMID:23583632 8-Br-cAMP multiple interactions ISO RGD:737520 6480464 [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP19A1 mRNA CTD PMID:21610156 8-Br-cAMP increases activity ISO RGD:1606587 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein CTD PMID:10746939 , PMID:18815356 8-Br-cAMP increases expression ISO RGD:1606587 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 mRNA CTD PMID:18815356 more ... 8-Br-cAMP increases activity EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein CTD PMID:21126571 , PMID:22120136 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 mRNA, 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 protein CTD PMID:21126571 , PMID:23583632 9-cis-retinoic acid multiple interactions EXP 6480464 Alitretinoin promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA] CTD PMID:12706301 9-cis-retinoic acid increases expression ISO RGD:1606587 6480464 Alitretinoin results in increased expression of CYP19A1 mRNA CTD PMID:15941851 9-cis-retinoic acid multiple interactions ISO RGD:1606587 6480464 [Alitretinoin binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein more ... CTD PMID:15941851 , PMID:16357189 9-cis-retinoic acid decreases expression EXP 6480464 Alitretinoin results in decreased expression of CYP19A1 mRNA CTD PMID:12706301 acetaldehyde multiple interactions ISO RGD:737520 6480464 [CGA protein results in increased abundance of Acetaldehyde] which results in increased expression of CYP19A1 mRNA CTD PMID:22285649 afimoxifene increases expression ISO RGD:1606587 6480464 afimoxifene results in increased expression of CYP19A1 mRNA CTD PMID:19549922 afimoxifene increases metabolic processing ISO RGD:1606587 6480464 CYP19A1 protein results in increased metabolism of afimoxifene CTD PMID:29285606 afimoxifene multiple interactions ISO RGD:1606587 6480464 [CYP19A1 protein results in increased metabolism of afimoxifene] which results in increased abundance of afimoxifene metabolite CTD PMID:29285606 Aflatoxicol multiple interactions ISO RGD:1606587 6480464 [CYP19A1 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of aflatoxicol more ... CTD PMID:21296134 aflatoxin B1 increases metabolic processing ISO RGD:1606587 6480464 CYP19A1 protein results in increased metabolism of Aflatoxin B1 CTD PMID:21296134 aflatoxin B1 multiple interactions ISO RGD:1606587 6480464 [CYP19A1 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of aflatoxicol more ... CTD PMID:21296134 , PMID:23402939 aflatoxin B1 increases expression ISO RGD:1606587 6480464 Aflatoxin B1 results in increased expression of CYP19A1 mRNA, Aflatoxin B1 results in increased expression of CYP19A1 protein CTD PMID:21296134 more ... AH23848 multiple interactions ISO RGD:1606587 6480464 AH 23848 inhibits the reaction [LEP protein results in increased expression of CYP19A1 mRNA] more ... CTD PMID:20678559 , PMID:28571770 albuterol multiple interactions ISO RGD:1606587 6480464 [Cyproterone co-treated with Albuterol] results in decreased expression of CYP19A1 CTD PMID:17822730 aldrin increases expression ISO RGD:1606587 6480464 Aldrin results in increased expression of CYP19A1 mRNA CTD PMID:16996190 aldrin increases activity ISO RGD:1606587 6480464 Aldrin results in increased activity of CYP19A1 protein CTD PMID:16996190 alginic acid decreases expression ISO RGD:737520 6480464 Alginic Acid results in decreased expression of CYP19A1 protein CTD PMID:35066102 all-trans-retinoic acid multiple interactions ISO RGD:1606587 6480464 [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of CYP19A1 mRNA CTD PMID:16443354 all-trans-retinoic acid increases expression ISO RGD:1606587 6480464 Tretinoin results in increased expression of CYP19A1 mRNA CTD PMID:15941851 allethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA CTD PMID:33051911 , PMID:33396045 alpha-naphthoflavone multiple interactions ISO RGD:1606587 6480464 [alpha-naphthoflavone results in decreased activity of CYP19A1 protein] which results in decreased susceptibility to o more ... CTD PMID:20678559 more ... alpha-naphthoflavone increases expression ISO RGD:1606587 6480464 alpha-naphthoflavone results in increased expression of CYP19A1 protein CTD PMID:20823264 alternariol increases expression ISO RGD:1606587 6480464 alternariol results in increased expression of CYP19A1 mRNA CTD PMID:23665424 aminoglutethimide multiple interactions ISO RGD:1606587 6480464 Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA] more ... CTD PMID:15242824 , PMID:16935330 aminoglutethimide increases activity ISO RGD:1606587 6480464 Aminoglutethimide results in increased activity of CYP19A1 protein CTD PMID:20087668 aminoglutethimide decreases activity ISO RGD:1606587 6480464 Aminoglutethimide results in decreased activity of CYP19A1 protein CTD PMID:15968818 , PMID:17910019 amitraz increases expression EXP 6480464 amitraz results in increased expression of CYP19A1 mRNA, amitraz results in increased expression of CYP19A1 protein CTD PMID:28463726 amlodipine decreases activity ISO RGD:1606587 6480464 Amlodipine results in decreased activity of CYP19A1 protein CTD PMID:26141389 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP19A1 mRNA CTD PMID:16483693 amoxicillin increases expression ISO RGD:1606587 6480464 Amoxicillin results in increased expression of CYP19A1 CTD PMID:17822730 amphetamine decreases response to substance ISO RGD:737520 6480464 CYP19A1 gene results in decreased susceptibility to Amphetamine CTD PMID:12884966 anastrozole decreases activity ISO RGD:1606587 6480464 Anastrozole results in decreased activity of CYP19A1 protein CTD PMID:15837728 more ... androgen antagonist multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP19A1 mRNA CTD PMID:25607892 androst-4-ene-3,17-dione affects metabolic processing ISO RGD:1606587 6480464 CYP19A1 protein affects the metabolism of Androstenedione CTD PMID:12628686 more ... androst-4-ene-3,17-dione increases metabolic processing ISO RGD:1606587 6480464 CYP19A1 protein results in increased metabolism of Androstenedione CTD PMID:22120136 , PMID:26162595 androst-4-ene-3,17-dione decreases expression EXP 6480464 Androstenedione results in decreased expression of CYP19A1 mRNA CTD PMID:21439382 androst-4-ene-3,17-dione increases metabolic processing EXP 6480464 CYP19A1 protein results in increased metabolism of Androstenedione CTD PMID:16569475 androst-4-ene-3,17-dione multiple interactions EXP 6480464 [Androstenedione results in decreased expression of CYP19A1 mRNA] which results in decreased abundance of Estradiol more ... CTD PMID:21273442 , PMID:21439382 androst-4-ene-3,17-dione increases expression EXP 6480464 Androstenedione results in increased expression of CYP19A1 mRNA CTD PMID:21273442 androst-4-ene-3,17-dione multiple interactions ISO RGD:1606587 6480464 2 more ... CTD PMID:11522339 more ... androstane-3,17-diol increases expression EXP 6480464 Androstane-3, 17-diol results in increased expression of CYP19A1 mRNA CTD PMID:21273442 aniline decreases activity ISO RGD:1606587 6480464 aniline analog results in decreased activity of CYP19A1 protein CTD PMID:16480277 aniline decreases expression ISO RGD:1606587 6480464 aniline analog results in decreased expression of CYP19A1 mRNA CTD PMID:16480277 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1606587 6480464 pyrazolanthrone inhibits the reaction [LEP protein results in increased expression of CYP19A1 mRNA] more ... CTD PMID:20678559 , PMID:28571770 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:737520 6480464 pyrazolanthrone inhibits the reaction [bisphenol A results in increased expression of CYP19A1 mRNA], pyrazolanthrone inhibits the reaction [bisphenol A results in increased expression of CYP19A1 protein] CTD PMID:28697429 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [bisphenol A results in increased expression of and results in increased activity of CYP19A1 protein] CTD PMID:20096755 anthracene increases expression ISO RGD:1606587 6480464 anthracene results in increased expression of CYP19A1 protein CTD PMID:28803881 anthracene multiple interactions ISO RGD:1606587 6480464 [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein CTD PMID:28803881 apigenin decreases activity ISO RGD:1606587 6480464 Apigenin results in decreased activity of CYP19A1 protein CTD PMID:10403137 more ... apigenin decreases expression ISO RGD:1606587 6480464 Apigenin results in decreased expression of CYP19A1 mRNA CTD PMID:16965912 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP19A1 mRNA, Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP19A1 protein CTD PMID:29208485 Aroclor 1254 decreases activity ISO RGD:1606587 6480464 Chlorodiphenyl (54% Chlorine) results in decreased activity of CYP19A1 protein CTD PMID:17599374 Aroclor 1254 multiple interactions ISO RGD:1606587 6480464 [Chlorodiphenyl (54% Chlorine) co-treated with Atrazine] results in decreased activity of CYP19A1 protein CTD PMID:17599374 arotinoid acid increases expression ISO RGD:1606587 6480464 4-(2-(5 more ... CTD PMID:16996190 arotinoid acid increases activity ISO RGD:1606587 6480464 4-(2-(5 more ... CTD PMID:16996190 arsenite(3-) multiple interactions ISO RGD:1606587 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of CYP19A1 mRNA] CTD PMID:31646340 arsenite(3-) decreases expression ISO RGD:1606587 6480464 arsenite results in decreased expression of CYP19A1 mRNA CTD PMID:31646340 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of CYP19A1 mRNA CTD PMID:29574565 atrazine multiple interactions ISO RGD:1606587 6480464 1-Methyl-3-isobutylxanthine inhibits the reaction [Atrazine inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA]] more ... CTD PMID:10746939 more ... atrazine increases expression ISO RGD:1606587 6480464 Atrazine metabolite results in increased expression of CYP19A1 mRNA, Atrazine results in increased expression of CYP19A1 mRNA CTD PMID:10746939 more ... atrazine increases activity ISO RGD:1606587 6480464 Atrazine metabolite results in increased activity of CYP19A1 protein, Atrazine results in increased activity of CYP19A1 protein CTD PMID:10746939 more ... atrazine decreases activity ISO RGD:1606587 6480464 Atrazine results in decreased activity of CYP19A1 protein CTD PMID:17599374 atrazine increases expression ISO RGD:737520 6480464 Atrazine results in increased expression of CYP19A1 mRNA CTD PMID:20723554 , PMID:26518232 atrazine decreases expression ISO RGD:737520 6480464 Atrazine results in decreased expression of CYP19A1 protein CTD PMID:33766575 atrazine increases expression EXP 6480464 Atrazine results in increased expression of CYP19A1 mRNA CTD PMID:22120136 more ... atrazine increases activity EXP 6480464 Atrazine results in increased activity of CYP19A1 protein CTD PMID:21126571 atrazine multiple interactions EXP 6480464 Atrazine inhibits the reaction [Chorionic Gonadotropin results in increased expression of CYP19A1 mRNA] more ... CTD PMID:22120136 more ... atrazine affects expression EXP 6480464 Atrazine affects the expression of CYP19A1 protein CTD PMID:22285353 bazedoxifene multiple interactions ISO RGD:737520 6480464 bazedoxifene affects the reaction [Oxygen deficiency affects the expression of CYP19A1 mRNA] CTD PMID:28859903 benomyl increases activity ISO RGD:1606587 6480464 Benomyl results in increased activity of CYP19A1 protein CTD PMID:14691014 benomyl increases expression ISO RGD:1606587 6480464 Benomyl results in increased expression of CYP19A1 mRNA CTD PMID:14691014 , PMID:25543211 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in decreased expression of CYP19A1 mRNA, [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in decreased expression of CYP19A1 protein CTD PMID:20920559 benzo[a]pyrene multiple interactions ISO RGD:1606587 6480464 [bisphenol A co-treated with 2 more ... CTD PMID:34929288 benzo[a]pyrene affects methylation ISO RGD:1606587 6480464 Benzo(a)pyrene affects the methylation of CYP19A1 5' UTR, Benzo(a)pyrene affects the methylation of CYP19A1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1606587 6480464 Benzo(a)pyrene results in increased expression of CYP19A1 mRNA CTD PMID:20064835 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP19A1 mRNA, Benzo(a)pyrene results in decreased expression of CYP19A1 protein CTD PMID:20920559 benzofurans increases expression ISO RGD:1606587 6480464 Benzofurans results in increased expression of CYP19A1 mRNA CTD PMID:17447562 beta-naphthoflavone increases expression ISO RGD:1606587 6480464 beta-Naphthoflavone results in increased expression of CYP19A1 mRNA CTD PMID:19737606 beta-naphthoflavone decreases expression ISO RGD:1606587 6480464 beta-Naphthoflavone results in decreased expression of CYP19A1 mRNA CTD PMID:32858204 bezafibrate decreases activity ISO RGD:1606587 6480464 Bezafibrate results in decreased activity of CYP19A1 protein CTD PMID:19539015 bezafibrate multiple interactions ISO RGD:737520 6480464 Bezafibrate inhibits the reaction [CYP19A1 gene mutant form results in decreased expression of ACADM mRNA], Bezafibrate inhibits the reaction [CYP19A1 gene mutant form results in decreased expression of ACOX1 mRNA] CTD PMID:11929713 bezafibrate decreases expression ISO RGD:1606587 6480464 Bezafibrate results in decreased expression of CYP19A1 mRNA CTD PMID:19539015 bicalutamide multiple interactions EXP 6480464 bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP19A1 protein], bicalutamide inhibits the reaction [Testosterone results in increased expression of CYP19A1 protein] CTD PMID:21273442 bifenthrin multiple interactions EXP 6480464 bifenthrin inhibits the reaction [CGA protein results in increased expression of CYP19A1 mRNA] CTD PMID:21251947 bifenthrin increases expression ISO RGD:1606587 6480464 bifenthrin results in increased expression of CYP19A1 mRNA CTD PMID:24938463 bifonazole decreases activity ISO RGD:1606587 6480464 bifonazole results in decreased activity of CYP19A1 protein CTD PMID:15554355 , PMID:24496634 biochanin A multiple interactions ISO RGD:1606587 6480464 [Genistein co-treated with biochanin A co-treated with daidzein] results in decreased activity of CYP19A1 protein more ... CTD PMID:16965912 , PMID:9435150 biochanin A decreases expression ISO RGD:1606587 6480464 biochanin A results in decreased expression of CYP19A1 mRNA CTD PMID:16965912 biochanin A decreases activity ISO RGD:1606587 6480464 biochanin A results in decreased activity of CYP19A1 protein CTD PMID:16965912 biphenyl-4-ol increases activity ISO RGD:1606587 6480464 4-phenylphenol results in increased activity of CYP19A1 protein CTD PMID:30817981 biphenyl-4-ol increases expression ISO RGD:1606587 6480464 4-phenylphenol results in increased expression of CYP19A1 mRNA CTD PMID:30817981 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in decreased expression of CYP19A1 mRNA more ... CTD PMID:20920559 , PMID:25607892 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1606587 6480464 Diethylhexyl Phthalate results in increased expression of CYP19A1 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:737520 6480464 Diethylhexyl Phthalate results in increased expression of CYP19A1 mRNA CTD PMID:27405655 bis(2-ethylhexyl) phthalate affects expression ISO RGD:737520 6480464 Diethylhexyl Phthalate affects the expression of CYP19A1 mRNA CTD PMID:25701202 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:737520 6480464 Diethylhexyl Phthalate results in decreased expression of CYP19A1 mRNA CTD PMID:19874833 more ... bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:737520 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate] results in increased expression of CYP19A1 mRNA more ... CTD PMID:22828881 more ... bis(2-ethylhexyl) phthalate affects expression EXP 6480464 Diethylhexyl Phthalate affects the expression of CYP19A1 mRNA CTD PMID:20568448 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP19A1 mRNA CTD PMID:16763069 , PMID:19560483 bis(2-ethylhexyl) phthalate increases activity EXP 6480464 Diethylhexyl Phthalate results in increased activity of CYP19A1 protein CTD PMID:16949715 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of CYP19A1 mRNA, Diethylhexyl Phthalate results in decreased expression of CYP19A1 protein CTD PMID:20920559 , PMID:28871463 bis(2-ethylhexyl) phthalate decreases activity EXP 6480464 Diethylhexyl Phthalate results in decreased activity of CYP19A1 protein CTD PMID:16949715 bisphenol A multiple interactions ISO RGD:1606587 6480464 [bisphenol A co-treated with 2 more ... CTD PMID:17599374 more ... bisphenol A decreases methylation ISO RGD:1606587 6480464 bisphenol A results in decreased methylation of CYP19A1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:737520 6480464 bisphenol A results in decreased expression of CYP19A1 mRNA CTD PMID:32407858 bisphenol A affects expression ISO RGD:1606587 6480464 bisphenol A affects the expression of CYP19A1 mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:737520 6480464 bisphenol A affects the expression of CYP19A1 mRNA CTD PMID:28970132 bisphenol A increases expression ISO RGD:1606587 6480464 bisphenol A results in increased expression of CYP19A1 mRNA CTD PMID:25784278 more ... bisphenol A decreases activity ISO RGD:1606587 6480464 bisphenol A results in decreased activity of CYP19A1 protein CTD PMID:12849724 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP19A1 mRNA, bisphenol A results in decreased expression of CYP19A1 protein CTD PMID:18191889 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP19A1 mRNA, bisphenol A results in increased expression of CYP19A1 protein CTD PMID:20096755 more ... bisphenol A increases activity ISO RGD:1606587 6480464 bisphenol A results in increased activity of CYP19A1 protein CTD PMID:12849724 , PMID:30817981 bisphenol A multiple interactions ISO RGD:737520 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate] results in increased expression of CYP19A1 mRNA more ... CTD PMID:11985600 more ... bisphenol A increases expression ISO RGD:737520 6480464 bisphenol A results in increased expression of CYP19A1 mRNA, bisphenol A results in increased expression of CYP19A1 protein CTD PMID:21123812 more ... bisphenol A decreases expression ISO RGD:1606587 6480464 bisphenol A results in decreased expression of CYP19A1 mRNA, bisphenol A results in decreased expression of CYP19A1 protein CTD PMID:22120136 more ... bisphenol A multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of and results in increased activity of CYP19A1 protein] more ... CTD PMID:18191889 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP19A1 mRNA CTD PMID:22285353 , PMID:32450286 bisphenol F increases expression ISO RGD:737520 6480464 4, 4'-bisphenol F results in increased expression of CYP19A1 mRNA CTD PMID:30196065 bitertanol multiple interactions EXP 6480464 [bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion co-treated with terbutylazine] results in increased expression of CYP19A1 mRNA CTD PMID:23954766 bucladesine increases expression ISO RGD:1606587 6480464 Bucladesine results in increased expression of CYP19A1 mRNA CTD PMID:35987080 bucladesine multiple interactions ISO RGD:1606587 6480464 fluorene-9-bisphenol inhibits the reaction [Bucladesine results in increased expression of CYP19A1 mRNA] CTD PMID:35987080 Butylbenzyl phthalate decreases expression ISO RGD:737520 6480464 butylbenzyl phthalate results in decreased expression of CYP19A1 mRNA, butylbenzyl phthalate results in decreased expression of CYP19A1 protein CTD PMID:29029336 Butylbenzyl phthalate multiple interactions ISO RGD:1606587 6480464 butylbenzyl phthalate results in increased expression of and results in increased activity of CYP19A1 protein, Fulvestrant inhibits the reaction [butylbenzyl phthalate results in increased activity of CYP19A1 protein] CTD PMID:31016752 Butylbenzyl phthalate decreases activity ISO RGD:1606587 6480464 butylbenzyl phthalate results in decreased activity of CYP19A1 protein CTD PMID:27825933 Butylbenzyl phthalate multiple interactions ISO RGD:737520 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA more ... CTD PMID:28013214 more ... Butylparaben affects expression EXP 6480464 butylparaben affects the expression of CYP19A1 protein CTD PMID:26888303 Butylparaben decreases expression ISO RGD:1606587 6480464 butylparaben results in decreased expression of CYP19A1 mRNA, butylparaben results in decreased expression of CYP19A1 protein CTD PMID:23744433 Butylparaben increases activity ISO RGD:1606587 6480464 butylparaben results in increased activity of CYP19A1 protein CTD PMID:30817981 Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of CYP19A1 mRNA CTD PMID:26888303 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP19A1 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of CYP19A1 mRNA CTD PMID:25607892 Butylparaben decreases expression EXP 6480464 butylparaben results in decreased expression of CYP19A1 mRNA CTD PMID:27122241 Butylparaben increases expression ISO RGD:1606587 6480464 butylparaben results in increased expression of CYP19A1 mRNA CTD PMID:30817981 cadmium atom decreases expression ISO RGD:1606587 6480464 Cadmium results in decreased expression of CYP19A1 mRNA CTD PMID:24376830 , PMID:31646340 cadmium atom multiple interactions ISO RGD:1606587 6480464 Cadmium inhibits the reaction [Fulvestrant results in increased expression of CYP19A1 mRNA] CTD PMID:31646340 caffeine increases expression EXP 6480464 Caffeine results in increased expression of CYP19A1 mRNA, Caffeine results in increased expression of CYP19A1 protein CTD PMID:28111094 calcitriol multiple interactions ISO RGD:1606587 6480464 Calcitriol promotes the reaction [Dexamethasone results in increased activity of CYP19A1 protein] CTD PMID:15862960 calcitriol increases expression ISO RGD:1606587 6480464 Calcitriol results in increased expression of CYP19A1 mRNA CTD PMID:16002434 calcitriol increases activity ISO RGD:1606587 6480464 Calcitriol results in increased activity of CYP19A1 protein CTD PMID:15862960 cannabidiol multiple interactions ISO RGD:1606587 6480464 Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of CYP19A1 mRNA] CTD PMID:31953017 cannabidiol decreases activity ISO RGD:1606587 6480464 Cannabidiol results in decreased activity of CYP19A1 protein CTD PMID:31953017 carbendazim increases expression ISO RGD:1606587 6480464 carbendazim results in increased expression of CYP19A1 mRNA CTD PMID:14691014 carbendazim increases activity ISO RGD:1606587 6480464 carbendazim results in increased activity of CYP19A1 protein CTD PMID:14691014 carmustine decreases expression ISO RGD:1606587 6480464 Carmustine results in decreased expression of CYP19A1 mRNA CTD PMID:15980968 celecoxib decreases activity ISO RGD:1606587 6480464 Celecoxib results in decreased activity of CYP19A1 protein CTD PMID:15964185 celecoxib decreases expression ISO RGD:1606587 6480464 Celecoxib results in decreased expression of CYP19A1 mRNA CTD PMID:15964185 CGP 52608 multiple interactions ISO RGD:1606587 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP19A1 gene] CTD PMID:28238834 chlordecone multiple interactions ISO RGD:1606587 6480464 [Dichlorodiphenyl Dichloroethylene co-treated with Chlordecone] results in increased activity of CYP19A1 protein more ... CTD PMID:17599374 chlordecone decreases expression ISO RGD:737520 6480464 Chlordecone results in decreased expression of CYP19A1 mRNA CTD PMID:29980752 chlordecone increases expression ISO RGD:737520 6480464 Chlordecone results in increased expression of CYP19A1 mRNA CTD PMID:33711761 chlordecone decreases activity ISO RGD:1606587 6480464 Chlordecone results in decreased activity of CYP19A1 protein CTD PMID:17599374 chlorogenic acid increases expression EXP 6480464 Chlorogenic Acid results in increased expression of CYP19A1 protein CTD PMID:29899696 chlorpyrifos multiple interactions ISO RGD:1606587 6480464 [prochloraz co-treated with Chlorpyrifos co-treated with triflusulfuron-methyl] results in increased expression of CYP19A1 mRNA CTD PMID:25233012 chlorpyrifos increases expression ISO RGD:737520 6480464 Chlorpyrifos results in increased expression of CYP19A1 mRNA CTD PMID:36769379 Chorionic gonadotropin multiple interactions EXP 6480464 Atrazine inhibits the reaction [Chorionic Gonadotropin results in increased expression of CYP19A1 mRNA] CTD PMID:26923738 Chorionic gonadotropin increases expression EXP 6480464 Chorionic Gonadotropin results in increased expression of CYP19A1 mRNA CTD PMID:26923738 chromium(6+) multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CYP19A1 protein CTD PMID:33675932 chrysin decreases activity ISO RGD:1606587 6480464 chrysin results in decreased activity of CYP19A1 protein CTD PMID:10403137 , PMID:15319488 chrysin multiple interactions ISO RGD:1606587 6480464 chrysin binds to and results in decreased activity of CYP19A1 protein CTD PMID:9435150 citalopram decreases activity ISO RGD:1606587 6480464 Citalopram results in decreased activity of CYP19A1 protein CTD PMID:26162595 clotrimazole decreases activity ISO RGD:1606587 6480464 Clotrimazole results in decreased activity of CYP19A1 protein CTD PMID:15554355 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of CYP19A1 mRNA CTD PMID:27899881 colforsin daropate hydrochloride multiple interactions ISO RGD:1606587 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:16357189 more ... colforsin daropate hydrochloride multiple interactions EXP 6480464 RARRES2 protein inhibits the reaction [Colforsin results in increased expression of CYP19A1 protein] CTD PMID:22948218 colforsin daropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of CYP19A1 protein CTD PMID:22948218 colforsin daropate hydrochloride increases expression ISO RGD:737520 6480464 Colforsin results in increased expression of CYP19A1 mRNA CTD PMID:20723554 , PMID:22461451 colforsin daropate hydrochloride increases activity ISO RGD:1606587 6480464 Colforsin results in increased activity of CYP19A1 protein CTD PMID:14691014 more ... colforsin daropate hydrochloride increases expression ISO RGD:1606587 6480464 Colforsin results in increased expression of CYP19A1 mRNA CTD PMID:14691014 more ... copper atom increases expression ISO RGD:1606587 6480464 Copper results in increased expression of CYP19A1 mRNA CTD PMID:30641075 copper atom multiple interactions ISO RGD:1606587 6480464 Copper inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] more ... CTD PMID:34871762 copper atom affects expression ISO RGD:1606587 6480464 Copper affects the expression of CYP19A1 mRNA CTD PMID:34871762 copper(0) increases expression ISO RGD:1606587 6480464 Copper results in increased expression of CYP19A1 mRNA CTD PMID:30641075 copper(0) multiple interactions ISO RGD:1606587 6480464 Copper inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] more ... CTD PMID:34871762 copper(0) affects expression ISO RGD:1606587 6480464 Copper affects the expression of CYP19A1 mRNA CTD PMID:34871762 copper(II) sulfate decreases expression ISO RGD:1606587 6480464 Copper Sulfate results in decreased expression of CYP19A1 mRNA CTD PMID:19549813 cyanamide multiple interactions ISO RGD:737520 6480464 Cyanamide inhibits the reaction [CGA protein results in increased expression of CYP19A1 mRNA] CTD PMID:22285649 cycloheximide decreases activity ISO RGD:1606587 6480464 Cycloheximide results in decreased activity of CYP19A1 protein CTD PMID:16480277 cycloheximide decreases expression EXP 6480464 Cycloheximide results in decreased expression of CYP19A1 protein CTD PMID:21126571 cyclosporin A decreases expression ISO RGD:1606587 6480464 Cyclosporine results in decreased expression of CYP19A1 mRNA CTD PMID:20106945 more ... cyhalothrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA CTD PMID:33051911 , PMID:33396045 cyhexatin increases expression ISO RGD:1606587 6480464 cyhexatin results in increased expression of CYP19A1 mRNA CTD PMID:15941851 cypermethrin increases activity ISO RGD:1606587 6480464 cypermethrin results in increased activity of CYP19A1 protein CTD PMID:16996190 cypermethrin affects expression EXP 6480464 cypermethrin affects the expression of CYP19A1 mRNA CTD PMID:35605701 cypermethrin decreases expression ISO RGD:737520 6480464 cypermethrin results in decreased expression of CYP19A1 mRNA CTD PMID:35031408 cypermethrin increases expression ISO RGD:737520 6480464 cypermethrin results in increased expression of CYP19A1 mRNA CTD PMID:24810582 cypermethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA more ... CTD PMID:23954766 more ... cyproconazole multiple interactions ISO RGD:1606587 6480464 [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA CTD PMID:25233012 cyproterone multiple interactions ISO RGD:1606587 6480464 [Cyproterone co-treated with Albuterol] results in decreased expression of CYP19A1 CTD PMID:17822730 D-aspartic acid increases expression ISO RGD:737520 6480464 D-Aspartic Acid results in increased expression of CYP19A1 mRNA, D-Aspartic Acid results in increased expression of CYP19A1 protein CTD PMID:26189884 D-aspartic acid increases expression EXP 6480464 D-Aspartic Acid results in increased expression of CYP19A1 mRNA CTD PMID:26044185 D-aspartic acid decreases expression EXP 6480464 D-Aspartic Acid results in decreased expression of CYP19A1 protein CTD PMID:24439162 daidzein decreases activity ISO RGD:1606587 6480464 daidzein results in decreased activity of CYP19A1 protein CTD PMID:16023337 , PMID:16965912 daidzein multiple interactions ISO RGD:1606587 6480464 [Genistein co-treated with biochanin A co-treated with daidzein] results in decreased activity of CYP19A1 protein, [Genistein co-treated with biochanin A co-treated with daidzein] results in decreased expression of CYP19A1 mRNA CTD PMID:16965912 daidzein decreases expression ISO RGD:1606587 6480464 daidzein results in decreased expression of CYP19A1 mRNA CTD PMID:16965912 DDE multiple interactions ISO RGD:1606587 6480464 [Dichlorodiphenyl Dichloroethylene co-treated with bisphenol A] results in decreased activity of CYP19A1 protein more ... CTD PMID:15070871 more ... DDE decreases activity ISO RGD:1606587 6480464 Dichlorodiphenyl Dichloroethylene results in decreased activity of CYP19A1 protein CTD PMID:17599374 DDE multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA CTD PMID:25607892 DDE increases expression ISO RGD:1606587 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP19A1 mRNA CTD PMID:20924025 DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of CYP19A1 mRNA CTD PMID:12035542 DDE increases activity ISO RGD:1606587 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of CYP19A1 protein CTD PMID:15070871 DDT decreases expression EXP 6480464 DDT results in decreased expression of CYP19A1 mRNA CTD PMID:12035542 DDT increases expression ISO RGD:1606587 6480464 DDT results in increased expression of CYP19A1 mRNA CTD PMID:30817981 DDT increases expression ISO RGD:737520 6480464 DDT results in increased expression of CYP19A1 mRNA CTD PMID:28263910 DDT increases activity ISO RGD:1606587 6480464 DDT results in increased activity of CYP19A1 protein CTD PMID:30817981 decabromodiphenyl ether increases expression ISO RGD:737520 6480464 decabromobiphenyl ether results in increased expression of CYP19A1 protein CTD PMID:28572024 dehydroepiandrosterone increases metabolic processing ISO RGD:1606587 6480464 CYP19A1 protein results in increased metabolism of Dehydroepiandrosterone CTD PMID:16397352 dehydroepiandrosterone multiple interactions ISO RGD:1606587 6480464 Lipopolysaccharides inhibits the reaction [Dehydroepiandrosterone results in decreased activity of CYP19A1 protein] CTD PMID:10657851 dehydroepiandrosterone decreases activity ISO RGD:1606587 6480464 Dehydroepiandrosterone results in decreased activity of CYP19A1 protein CTD PMID:10657851 deoxynivalenol decreases expression ISO RGD:1606587 6480464 deoxynivalenol results in decreased expression of CYP19A1 mRNA CTD PMID:22982764 dexamethasone multiple interactions ISO RGD:1606587 6480464 Calcitriol promotes the reaction [Dexamethasone results in increased activity of CYP19A1 protein] CTD PMID:15862960 dexamethasone decreases expression ISO RGD:1606587 6480464 Dexamethasone results in decreased expression of CYP19A1 mRNA CTD PMID:25047013 dexamethasone increases activity ISO RGD:1606587 6480464 Dexamethasone results in increased activity of CYP19A1 protein CTD PMID:15862960 , PMID:16691199 dexamethasone increases expression ISO RGD:1606587 6480464 Dexamethasone results in increased expression of CYP19A1 mRNA CTD PMID:15525692 more ... dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP19A1 mRNA CTD PMID:19560483 dibutyl phthalate decreases expression ISO RGD:1606587 6480464 Dibutyl Phthalate results in decreased expression of CYP19A1 mRNA CTD PMID:28104404 dibutyl phthalate decreases activity ISO RGD:1606587 6480464 Dibutyl Phthalate results in decreased activity of CYP19A1 protein CTD PMID:27825933 dibutyl phthalate multiple interactions ISO RGD:737520 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA more ... CTD PMID:28013214 more ... dibutyl phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA CTD PMID:25607892 dibutyl phthalate decreases expression ISO RGD:737520 6480464 Dibutyl Phthalate results in decreased expression of CYP19A1 mRNA CTD PMID:29029336 dibutyl phthalate increases expression ISO RGD:737520 6480464 Dibutyl Phthalate results in increased expression of CYP19A1 mRNA CTD PMID:25765776 dibutylstannane decreases activity ISO RGD:1606587 6480464 di-n-butyltin analog results in decreased activity of CYP19A1 protein CTD PMID:11751016 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of CYP19A1 mRNA CTD PMID:18636392 dichlorine increases expression EXP 6480464 Chlorine results in increased expression of CYP19A1 mRNA CTD PMID:18636392 dicofol decreases activity ISO RGD:1606587 6480464 Dicofol results in decreased activity of CYP19A1 protein CTD PMID:10806373 dicrotophos decreases expression ISO RGD:1606587 6480464 dicrotophos results in decreased expression of CYP19A1 mRNA CTD PMID:28302478 dienogest decreases expression ISO RGD:1606587 6480464 dienogest results in decreased expression of CYP19A1 mRNA, dienogest results in decreased expression of CYP19A1 protein CTD PMID:22130322 diethyl phthalate increases expression EXP 6480464 diethyl phthalate results in increased expression of CYP19A1 mRNA, diethyl phthalate results in increased expression of CYP19A1 protein CTD PMID:24994688 diethyl phthalate multiple interactions ISO RGD:737520 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA, [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP19A1 mRNA CTD PMID:28013214 , PMID:34597818 diethyl phthalate multiple interactions ISO RGD:1606587 6480464 diethyl phthalate promotes the reaction [ESR1 protein binds to CYP19A1 promoter], Tamoxifen inhibits the reaction [diethyl phthalate promotes the reaction [ESR1 protein binds to CYP19A1 promoter]] CTD PMID:24994688 diethyl phthalate increases expression ISO RGD:1606587 6480464 diethyl phthalate results in increased expression of CYP19A1 protein CTD PMID:24994688 diethylstilbestrol multiple interactions EXP 6480464 Diethylstilbestrol promotes the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] CTD PMID:15878960 diethylstilbestrol affects expression EXP 6480464 Diethylstilbestrol affects the expression of CYP19A1 mRNA CTD PMID:36653537 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CYP19A1 mRNA CTD PMID:35605701 diethylstilbestrol decreases activity ISO RGD:1606587 6480464 Diethylstilbestrol results in decreased activity of CYP19A1 protein CTD PMID:17599374 , PMID:36374910 diethylstilbestrol increases expression ISO RGD:737520 6480464 Diethylstilbestrol results in increased expression of CYP19A1 mRNA CTD PMID:22100434 , PMID:28970132 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CYP19A1 mRNA, Diethylstilbestrol results in increased expression of CYP19A1 protein CTD PMID:15525594 diisobutyl phthalate multiple interactions ISO RGD:737520 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA, [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP19A1 mRNA CTD PMID:28013214 , PMID:34597818 diisononyl phthalate multiple interactions ISO RGD:737520 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA, [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP19A1 mRNA CTD PMID:28013214 , PMID:34597818 dimethoate increases expression ISO RGD:737520 6480464 Dimethoate results in increased expression of CYP19A1 mRNA CTD PMID:23943137 dioxygen multiple interactions ISO RGD:737520 6480464 bazedoxifene affects the reaction [Oxygen deficiency affects the expression of CYP19A1 mRNA] CTD PMID:28859903 dioxygen affects expression ISO RGD:737520 6480464 Oxygen deficiency affects the expression of CYP19A1 mRNA CTD PMID:28859903 dipentyl phthalate increases expression EXP 6480464 di-n-pentyl phthalate results in increased expression of CYP19A1 mRNA CTD PMID:19560483 disulfiram multiple interactions ISO RGD:737520 6480464 Disulfiram inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP19A1 mRNA] CTD PMID:22285649 doxorubicin increases expression ISO RGD:1606587 6480464 Doxorubicin results in increased expression of CYP19A1 mRNA CTD PMID:32505695 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CYP19A1 mRNA CTD PMID:32810592 doxorubicin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased expression of CYP19A1 mRNA], Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of CYP19A1 mRNA] CTD PMID:32810592 E-4031 decreases response to substance ISO RGD:737520 6480464 CYP19A1 gene mutant form results in decreased susceptibility to E 4031 CTD PMID:25972195 endosulfan increases activity ISO RGD:1606587 6480464 Endosulfan results in increased activity of CYP19A1 protein CTD PMID:16996190 enilconazole decreases activity ISO RGD:1606587 6480464 enilconazole results in decreased activity of CYP19A1 protein CTD PMID:10806373 more ... enilconazole affects secretion ISO RGD:737520 6480464 enilconazole affects the secretion of CYP19A1 mRNA CTD PMID:30853599 enniatin increases expression ISO RGD:1606587 6480464 enniatins results in increased expression of CYP19A1 mRNA CTD PMID:25625232 Enterolactone decreases activity ISO RGD:1606587 6480464 2, 3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of CYP19A1 protein CTD PMID:15876411 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP19A1 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of CYP19A1 mRNA CTD PMID:25607892 epoxiconazole multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA CTD PMID:25607892 epoxiconazole multiple interactions ISO RGD:1606587 6480464 [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA CTD PMID:25233012 equol decreases expression ISO RGD:737520 6480464 Equol results in decreased expression of CYP19A1 mRNA CTD PMID:26876617 erlotinib hydrochloride decreases activity ISO RGD:1606587 6480464 Erlotinib Hydrochloride results in decreased activity of CYP19A1 protein CTD PMID:26141389 erythrosin B decreases activity EXP 6480464 Erythrosine results in decreased activity of CYP19A1 protein CTD PMID:18310892 estriol multiple interactions ISO RGD:1606587 6480464 Estriol inhibits the reaction [Aflatoxin B1 results in increased expression of CYP19A1 mRNA] CTD PMID:21296134 estriol decreases expression ISO RGD:1606587 6480464 Estriol results in decreased expression of CYP19A1 mRNA CTD PMID:21296134 estrone affects chemical synthesis ISO RGD:1606587 6480464 CYP19A1 protein affects the chemical synthesis of Estrone CTD PMID:16030167 estrone multiple interactions ISO RGD:1606587 6480464 [Fluconazole results in decreased activity of CYP19A1 protein] which results in decreased chemical synthesis of Estrone more ... CTD PMID:16030167 more ... estrone increases chemical synthesis ISO RGD:1606587 6480464 CYP19A1 protein results in increased chemical synthesis of Estrone CTD PMID:16054388 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP19A1 mRNA, Ethanol results in increased expression of CYP19A1 protein CTD PMID:29769550 ethanol multiple interactions ISO RGD:1606587 6480464 [2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine co-treated with Ethanol] results in increased activity of CYP19A1 protein CTD PMID:32113805 ethosuximide decreases activity ISO RGD:1606587 6480464 Ethosuximide results in decreased activity of CYP19A1 protein CTD PMID:17959350 exemestane decreases activity ISO RGD:1606587 6480464 exemestane results in decreased activity of CYP19A1 protein CTD PMID:15837728 more ... farnesol increases activity EXP 6480464 Farnesol results in increased activity of CYP19A1 protein CTD PMID:15840382 fenarimol decreases activity ISO RGD:1606587 6480464 fenarimol results in decreased activity of CYP19A1 protein CTD PMID:10806373 more ... fenarimol increases expression ISO RGD:737520 6480464 fenarimol results in increased expression of CYP19A1 mRNA, fenarimol results in increased expression of CYP19A1 protein CTD PMID:21722721 fenbuconazole decreases activity ISO RGD:1606587 6480464 fenbuconazole results in decreased activity of CYP19A1 protein CTD PMID:16996190 fentin chloride increases expression ISO RGD:1606587 6480464 triphenyltin chloride results in increased expression of CYP19A1 mRNA CTD PMID:15941851 fentin hydroxide multiple interactions ISO RGD:1606587 6480464 [triphenyltin hydroxide binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein CTD PMID:15941851 fentin hydroxide increases expression ISO RGD:1606587 6480464 triphenyltin hydroxide results in increased expression of CYP19A1 mRNA CTD PMID:15941851 fenvalerate multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA CTD PMID:33051911 , PMID:33396045 finasteride multiple interactions EXP 6480464 Finasteride promotes the reaction [Androstenedione results in increased expression of CYP19A1 mRNA], Finasteride promotes the reaction [Testosterone results in increased expression of CYP19A1 mRNA] CTD PMID:21273442 finasteride multiple interactions ISO RGD:1606587 6480464 [Finasteride co-treated with Testosterone] results in increased expression of CYP19A1 mRNA more ... CTD PMID:23523586 fingolimod hydrochloride decreases expression ISO RGD:1606587 6480464 Fingolimod Hydrochloride results in decreased expression of CYP19A1 mRNA CTD PMID:29654831 flavanones decreases activity ISO RGD:1606587 6480464 Flavanones results in decreased activity of CYP19A1 protein CTD PMID:17910019 flavone increases activity ISO RGD:1606587 6480464 flavone results in increased activity of CYP19A1 protein CTD PMID:15319488 flavones decreases activity ISO RGD:1606587 6480464 Flavones results in decreased activity of CYP19A1 protein CTD PMID:17910019 flavonoids decreases activity ISO RGD:1606587 6480464 Flavonoids analog results in decreased activity of CYP19A1 protein CTD PMID:15319488 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CYP19A1 mRNA CTD PMID:18035473 fluconazole multiple interactions ISO RGD:1606587 6480464 [Fluconazole results in decreased activity of CYP19A1 protein] which results in decreased chemical synthesis of Estrone, [Fluconazole results in decreased activity of CYP19A1 protein] which results in decreased metabolism of Androstenedione CTD PMID:31330226 fluconazole decreases activity ISO RGD:1606587 6480464 Fluconazole results in decreased activity of CYP19A1 protein CTD PMID:31330226 flufenoxuron increases expression ISO RGD:737520 6480464 flufenoxuron results in increased expression of CYP19A1 mRNA CTD PMID:33771252 fluoxetine decreases activity ISO RGD:1606587 6480464 Fluoxetine results in decreased activity of CYP19A1 protein CTD PMID:26162595 flusilazole decreases activity ISO RGD:1606587 6480464 flusilazole results in decreased activity of CYP19A1 protein CTD PMID:15554355 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CYP19A1 mRNA CTD PMID:26485406 fluvoxamine decreases activity ISO RGD:1606587 6480464 Fluvoxamine results in decreased activity of CYP19A1 protein CTD PMID:26162595 formestane multiple interactions EXP 6480464 formestane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein] more ... CTD PMID:21273442 , PMID:22120136 formestane decreases activity ISO RGD:1606587 6480464 formestane results in decreased activity of CYP19A1 protein CTD PMID:10806373 more ... formestane multiple interactions ISO RGD:1606587 6480464 formestane inhibits the reaction [Atrazine results in increased activity of CYP19A1 protein] more ... CTD PMID:10746939 , PMID:15242824 formestane decreases activity EXP 6480464 formestane results in decreased activity of CYP19A1 protein CTD PMID:17895526 more ... fulvestrant decreases activity ISO RGD:1606587 6480464 fulvestrant results in decreased activity of CYP19A1 protein CTD PMID:11850205 , PMID:15976552 fulvestrant multiple interactions EXP 6480464 Fulvestrant inhibits the reaction [Estradiol results in increased expression of CYP19A1 mRNA] CTD PMID:36931579 fulvestrant multiple interactions ISO RGD:1606587 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of CYP19A1 mRNA] more ... CTD PMID:31016752 more ... fulvestrant increases expression ISO RGD:1606587 6480464 Fulvestrant results in increased expression of CYP19A1 mRNA CTD PMID:31646340 gallic acid decreases activity EXP 6480464 Gallic Acid results in decreased activity of CYP19A1 protein CTD PMID:18310892 gamma-hexachlorocyclohexane multiple interactions ISO RGD:1606587 6480464 Hexachlorocyclohexane inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA] CTD PMID:17080404 gamma-hexachlorocyclohexane increases expression ISO RGD:1606587 6480464 Hexachlorocyclohexane results in increased expression of CYP19A1 mRNA CTD PMID:17080404 gamma-hexachlorocyclohexane increases activity ISO RGD:1606587 6480464 Hexachlorocyclohexane results in increased activity of CYP19A1 protein CTD PMID:12849724 gamma-hexachlorocyclohexane decreases activity ISO RGD:1606587 6480464 Hexachlorocyclohexane results in decreased activity of CYP19A1 protein CTD PMID:12849724 Geniposidic acid increases expression EXP 6480464 geniposidic acid results in increased expression of CYP19A1 protein CTD PMID:29899696 genistein multiple interactions ISO RGD:1606587 6480464 [Genistein co-treated with biochanin A co-treated with daidzein] results in decreased activity of CYP19A1 protein more ... CTD PMID:16965912 , PMID:21854827 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of CYP19A1 mRNA CTD PMID:21782745 genistein decreases expression EXP 6480464 Genistein results in decreased expression of CYP19A1 mRNA CTD PMID:12035542 genistein decreases activity ISO RGD:1606587 6480464 Genistein results in decreased activity of CYP19A1 protein CTD PMID:15876411 more ... genistein increases activity ISO RGD:1606587 6480464 Genistein results in increased activity of CYP19A1 protein CTD PMID:15319488 genistein increases expression ISO RGD:1606587 6480464 Genistein results in increased expression of CYP19A1 mRNA, Genistein results in increased expression of CYP19A1 protein CTD PMID:15319488 more ... genistein decreases expression ISO RGD:1606587 6480464 Genistein results in decreased expression of CYP19A1 mRNA CTD PMID:16965912 glyphosate multiple interactions ISO RGD:1606587 6480464 [glyphosate co-treated with Herbicides] affects the activity of CYP19A1 protein, [glyphosate co-treated with Herbicides] affects the expression of CYP19A1 mRNA CTD PMID:19539684 glyphosate increases expression ISO RGD:737520 6480464 glyphosate results in increased expression of CYP19A1 mRNA CTD PMID:30245445 glyphosate decreases expression ISO RGD:1606587 6480464 glyphosate results in decreased expression of CYP19A1 mRNA CTD PMID:15929894 glyphosate decreases activity ISO RGD:1606587 6480464 glyphosate results in decreased activity of CYP19A1 protein CTD PMID:15929894 more ... glyphosate affects binding ISO RGD:1606587 6480464 glyphosate binds to CYP19A1 protein CTD PMID:15929894 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of CYP19A1 mRNA, glyphosate results in increased expression of CYP19A1 protein CTD PMID:24930125 heptachlor decreases activity ISO RGD:1606587 6480464 Heptachlor results in decreased activity of CYP19A1 protein CTD PMID:16996190 herbicide decreases expression ISO RGD:1606587 6480464 Herbicides results in decreased expression of CYP19A1 mRNA CTD PMID:15929894 herbicide multiple interactions EXP 6480464 [perfluoro-n-nonanoic acid co-treated with [Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening Agents co-treated with Insecticides co-treated with Fungicides, Industrial co-treated with Herbicides]] results in increased expression of CYP19A1 mRNA CTD PMID:25588985 herbicide affects binding ISO RGD:1606587 6480464 Herbicides binds to CYP19A1 protein CTD PMID:15929894 herbicide multiple interactions ISO RGD:1606587 6480464 [glyphosate co-treated with Herbicides] affects the activity of CYP19A1 protein, [glyphosate co-treated with Herbicides] affects the expression of CYP19A1 mRNA CTD PMID:19539684 herbicide decreases activity ISO RGD:1606587 6480464 Herbicides results in decreased activity of CYP19A1 protein CTD PMID:15929894 , PMID:17486286 herbicide increases expression EXP 6480464 Herbicides results in increased expression of CYP19A1 mRNA, Herbicides results in increased expression of CYP19A1 protein CTD PMID:24930125 hesperetin decreases activity ISO RGD:1606587 6480464 hesperetin results in decreased activity of CYP19A1 protein CTD PMID:10403137 hexachlorobenzene increases expression ISO RGD:1606587 6480464 Hexachlorobenzene results in increased expression of CYP19A1 protein CTD PMID:35181438 hexaconazole decreases activity ISO RGD:1606587 6480464 hexaconazole results in decreased activity of CYP19A1 protein CTD PMID:12127262 HT-2 toxin decreases expression ISO RGD:1606587 6480464 HT-2 toxin results in decreased expression of CYP19A1 mRNA CTD PMID:22982764 ibuprofen decreases activity ISO RGD:1606587 6480464 Ibuprofen results in decreased activity of CYP19A1 protein CTD PMID:15964185 ibuprofen decreases expression ISO RGD:1606587 6480464 Ibuprofen results in decreased expression of CYP19A1 mRNA CTD PMID:15964185 imidacloprid increases activity ISO RGD:1606587 6480464 imidacloprid results in increased activity of CYP19A1 protein CTD PMID:28750898 imidacloprid affects expression ISO RGD:1606587 6480464 imidacloprid affects the expression of CYP19A1 mRNA CTD PMID:29701941 imidacloprid multiple interactions ISO RGD:1606587 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:29701941 indirubin increases expression ISO RGD:1606587 6480464 indirubin results in increased expression of CYP19A1 mRNA CTD PMID:15056799 indometacin decreases activity ISO RGD:1606587 6480464 Indomethacin results in decreased activity of CYP19A1 protein CTD PMID:15964185 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CYP19A1 mRNA CTD PMID:18299717 indometacin decreases expression ISO RGD:1606587 6480464 Indomethacin results in decreased expression of CYP19A1 mRNA CTD PMID:15964185 iodoacetic acid decreases expression ISO RGD:737520 6480464 Iodoacetic Acid results in decreased expression of CYP19A1 mRNA CTD PMID:31693920 iprodione increases activity ISO RGD:1606587 6480464 iprodione results in increased activity of CYP19A1 protein CTD PMID:11884232 isoliquiritigenin decreases expression ISO RGD:737520 6480464 isoliquiritigenin results in decreased expression of CYP19A1 mRNA CTD PMID:27773742 ketoconazole increases activity ISO RGD:1606587 6480464 Ketoconazole results in increased activity of CYP19A1 protein CTD PMID:20087668 , PMID:31330226 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of CYP19A1 mRNA CTD PMID:36653537 ketoconazole multiple interactions ISO RGD:1606587 6480464 [Ketoconazole results in increased activity of CYP19A1 protein] which results in increased chemical synthesis of Estrone, [Ketoconazole results in increased activity of CYP19A1 protein] which results in increased metabolism of Androstenedione CTD PMID:31330226 ketoconazole decreases activity ISO RGD:1606587 6480464 Ketoconazole results in decreased activity of CYP19A1 protein CTD PMID:27159630 , PMID:36374910 L-ascorbic acid multiple interactions ISO RGD:1606587 6480464 [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of CYP19A1 mRNA CTD PMID:16443354 L-ascorbic acid increases expression ISO RGD:1606587 6480464 Ascorbic Acid results in increased expression of CYP19A1 mRNA CTD PMID:17901237 lamotrigine decreases activity ISO RGD:1606587 6480464 lamotrigine results in decreased activity of CYP19A1 protein CTD PMID:17959350 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of CYP19A1 mRNA CTD PMID:31054310 lead diacetate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [lead acetate results in decreased expression of CYP19A1 mRNA] CTD PMID:31054310 leflunomide increases expression ISO RGD:1606587 6480464 leflunomide results in increased expression of CYP19A1 mRNA CTD PMID:28988120 letrozole multiple interactions EXP 6480464 letrozole binds to and results in decreased activity of CYP19A1 protein CTD PMID:24902786 letrozole multiple interactions ISO RGD:737520 6480464 diacerein inhibits the reaction [Letrozole results in decreased expression of CYP19A1 mRNA] CTD PMID:37030623 letrozole decreases expression ISO RGD:737520 6480464 Letrozole results in decreased expression of CYP19A1 mRNA CTD PMID:37030623 letrozole decreases activity ISO RGD:737520 6480464 letrozole results in decreased activity of CYP19A1 protein CTD PMID:15967659 letrozole increases activity ISO RGD:1606587 6480464 letrozole results in increased activity of CYP19A1 protein CTD PMID:20087668 letrozole decreases activity ISO RGD:1606587 6480464 Letrozole results in decreased activity of CYP19A1 protein CTD PMID:15837728 more ... letrozole multiple interactions ISO RGD:1606587 6480464 Letrozole inhibits the reaction [[sodium arsenite results in increased activity of CYP19A1 protein] which results in increased abundance of Estradiol] more ... CTD PMID:24068038 , PMID:32197950 leuprolide multiple interactions ISO RGD:737520 6480464 [Leuprolide co-treated with Testosterone] results in decreased expression of CYP19A1 mRNA CTD PMID:16032706 levetiracetam decreases expression ISO RGD:1606587 6480464 Levetiracetam results in decreased expression of CYP19A1 mRNA CTD PMID:19566492 linuron multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA CTD PMID:25607892 lipopolysaccharide multiple interactions ISO RGD:1606587 6480464 Lipopolysaccharides inhibits the reaction [Dehydroepiandrosterone results in decreased activity of CYP19A1 protein] CTD PMID:10657851 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of and results in increased activity of CYP19A1 protein] CTD PMID:20096755 LY294002 multiple interactions ISO RGD:1606587 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LEP protein results in increased expression of CYP19A1 mRNA] more ... CTD PMID:20678559 , PMID:28571770 malathion multiple interactions EXP 6480464 [bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion co-treated with terbutylazine] results in increased expression of CYP19A1 mRNA CTD PMID:23954766 medroxyprogesterone acetate multiple interactions ISO RGD:1606587 6480464 [Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of CYP19A1 mRNA more ... CTD PMID:31953017 melamine increases activity ISO RGD:1606587 6480464 melamine results in increased activity of CYP19A1 protein CTD PMID:32113805 melatonin decreases expression ISO RGD:1606587 6480464 Melatonin results in decreased expression of CYP19A1 CTD PMID:16080194 melatonin decreases activity EXP 6480464 Melatonin results in decreased activity of CYP19A1 protein CTD PMID:16080194 mestranol increases expression ISO RGD:737520 6480464 Mestranol results in increased expression of CYP19A1 mRNA CTD PMID:36098747 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [FSHB protein results in increased expression of CYP19A1 protein] CTD PMID:16760380 methadone multiple interactions ISO RGD:1606587 6480464 Aminoglutethimide inhibits the reaction [CYP19A1 protein affects the metabolism of Methadone], formestane inhibits the reaction [CYP19A1 protein affects the metabolism of Methadone] CTD PMID:15242824 methadone affects metabolic processing ISO RGD:1606587 6480464 CYP19A1 protein affects the metabolism of Methadone CTD PMID:15242824 methomyl increases activity ISO RGD:1606587 6480464 Methomyl results in increased activity of CYP19A1 protein CTD PMID:11884232 methotrexate affects expression ISO RGD:737520 6480464 Methotrexate affects the expression of CYP19A1 mRNA CTD PMID:18502557 methotrexate increases expression ISO RGD:1606587 6480464 Methotrexate results in increased expression of CYP19A1 mRNA CTD PMID:17400583 methoxychlor increases activity ISO RGD:1606587 6480464 Methoxychlor results in increased activity of CYP19A1 protein CTD PMID:16996190 , PMID:30817981 methoxychlor increases expression ISO RGD:737520 6480464 Methoxychlor results in increased expression of CYP19A1 mRNA CTD PMID:25048109 methoxychlor decreases activity EXP 6480464 Methoxychlor metabolite results in decreased activity of CYP19A1 protein CTD PMID:23326527 methoxychlor decreases expression ISO RGD:737520 6480464 Methoxychlor results in decreased expression of CYP19A1 mRNA CTD PMID:21514315 methoxychlor affects expression EXP 6480464 Methoxychlor affects the expression of CYP19A1 mRNA CTD PMID:22120136 , PMID:22285353 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of CYP19A1 protein CTD PMID:22285353 methoxychlor multiple interactions ISO RGD:1606587 6480464 Methoxychlor affects the reaction [CYP19A1 protein results in increased metabolism of Androstenedione] CTD PMID:22120136 methoxychlor affects expression ISO RGD:1606587 6480464 Methoxychlor affects the expression of CYP19A1 mRNA CTD PMID:22120136 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of CYP19A1 mRNA more ... CTD PMID:16737795 more ... methoxychlor increases expression ISO RGD:1606587 6480464 Methoxychlor results in increased expression of CYP19A1 mRNA CTD PMID:16996190 methylmercury chloride multiple interactions ISO RGD:1606587 6480464 [Tetrachlorodibenzodioxin co-treated with 3 more ... CTD PMID:25765474 methylparaben affects expression ISO RGD:1606587 6480464 methylparaben affects the expression of CYP19A1 mRNA, methylparaben affects the expression of CYP19A1 protein CTD PMID:23744433 methyltestosterone multiple interactions ISO RGD:1606587 6480464 Methyltestosterone inhibits the reaction [CYP19A1 protein affects the metabolism of Androstenedione] CTD PMID:12628686 metolachlor increases activity ISO RGD:1606587 6480464 metolachlor results in increased activity of CYP19A1 protein CTD PMID:16996190 miconazole decreases activity ISO RGD:1606587 6480464 Miconazole results in decreased activity of CYP19A1 protein CTD PMID:15554355 microcystin-LR affects expression ISO RGD:737520 6480464 cyanoginosin LR affects the expression of CYP19A1 protein CTD PMID:28189720 mono(2-ethylhexyl) phthalate decreases activity ISO RGD:1606587 6480464 mono-(2-ethylhexyl)phthalate results in decreased activity of CYP19A1 protein CTD PMID:19501113 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:737520 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP19A1 mRNA CTD PMID:31884101 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1606587 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CYP19A1 mRNA CTD PMID:29089286 mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 alitretinoin promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA] CTD PMID:12706301 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA CTD PMID:12706301 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:737520 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA CTD PMID:19874833 , PMID:22401849 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1606587 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA CTD PMID:19501113 , PMID:22401849 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1606587 6480464 mono-(2-ethylhexyl)phthalate inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA] CTD PMID:19822197 monobenzyl phthalate affects expression ISO RGD:1606587 6480464 mono-benzyl phthalate affects the expression of CYP19A1 mRNA CTD PMID:28381288 monobenzyl phthalate multiple interactions ISO RGD:737520 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP19A1 mRNA CTD PMID:31884101 Monobutylphthalate affects expression ISO RGD:1606587 6480464 monobutyl phthalate affects the expression of CYP19A1 mRNA CTD PMID:28381288 monoethyl phthalate multiple interactions ISO RGD:737520 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP19A1 mRNA CTD PMID:31884101 monoethyl phthalate increases expression ISO RGD:1606587 6480464 monoethyl phthalate results in increased expression of CYP19A1 mRNA CTD PMID:29089286 mycotoxin increases expression ISO RGD:1606587 6480464 Mycotoxins results in increased expression of CYP19A1 mRNA CTD PMID:23665424 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:1606587 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LEP protein results in increased expression of CYP19A1 protein] more ... CTD PMID:19147701 more ... N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [bisphenol A results in increased expression of and results in increased activity of CYP19A1 protein] CTD PMID:20096755 N-Nitrosopyrrolidine increases expression ISO RGD:1606587 6480464 N-Nitrosopyrrolidine results in increased expression of CYP19A1 mRNA CTD PMID:32234424 nandrolone multiple interactions ISO RGD:1606587 6480464 Nandrolone inhibits the reaction [CYP19A1 protein affects the metabolism of Androstenedione] CTD PMID:12628686 naphthalene decreases expression ISO RGD:737520 6480464 naphthalene results in decreased expression of CYP19A1 mRNA CTD PMID:31020322 naphthalene multiple interactions ISO RGD:1606587 6480464 [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein CTD PMID:28803881 naphthalene increases expression ISO RGD:1606587 6480464 naphthalene results in increased expression of CYP19A1 protein CTD PMID:28803881 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of CYP19A1 mRNA, Nicotine results in decreased expression of CYP19A1 protein CTD PMID:30959089 nicotine increases activity ISO RGD:1606587 6480464 Nicotine results in increased activity of CYP19A1 protein CTD PMID:32113805 nicotine multiple interactions ISO RGD:1606587 6480464 Vecuronium Bromide inhibits the reaction [Nicotine results in decreased expression of CYP19A1 mRNA], Vecuronium Bromide inhibits the reaction [Nicotine results in decreased expression of CYP19A1 protein] CTD PMID:30959089 nicotine decreases expression ISO RGD:1606587 6480464 Nicotine results in decreased expression of CYP19A1 mRNA, Nicotine results in decreased expression of CYP19A1 protein CTD PMID:30959089 Niflumic acid decreases expression ISO RGD:1606587 6480464 Niflumic Acid results in decreased expression of CYP19A1 mRNA CTD PMID:15964185 Niflumic acid decreases activity ISO RGD:1606587 6480464 Niflumic Acid results in decreased activity of CYP19A1 protein CTD PMID:15964185 nimesulide decreases activity ISO RGD:1606587 6480464 nimesulide analog results in decreased activity of CYP19A1 protein more ... CTD PMID:15964185 more ... nimesulide decreases activity EXP 6480464 nimesulide results in decreased activity of CYP19A1 protein CTD PMID:23054057 nimesulide decreases expression ISO RGD:1606587 6480464 nimesulide analog results in decreased expression of CYP19A1 mRNA, nimesulide results in decreased expression of CYP19A1 mRNA CTD PMID:15964185 , PMID:20542113 nimesulide multiple interactions ISO RGD:1606587 6480464 nimesulide analog results in decreased activity of and results in decreased expression of CYP19A1 CTD PMID:17315855 Nonylphenol decreases activity ISO RGD:1606587 6480464 nonylphenol results in decreased activity of CYP19A1 protein CTD PMID:17599374 Nonylphenol increases activity ISO RGD:1606587 6480464 nonylphenol results in increased activity of CYP19A1 protein CTD PMID:27825933 Nonylphenol multiple interactions ISO RGD:1606587 6480464 [Dichlorodiphenyl Dichloroethylene co-treated with nonylphenol] results in increased activity of CYP19A1 protein more ... CTD PMID:17599374 NS-398 multiple interactions ISO RGD:1606587 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [LEP protein results in increased expression of CYP19A1 mRNA] more ... CTD PMID:20678559 , PMID:28571770 NS-398 decreases activity ISO RGD:1606587 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide analog results in decreased activity of CYP19A1 protein, N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of CYP19A1 protein CTD PMID:15964185 , PMID:16480277 NS-398 decreases expression ISO RGD:1606587 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide analog results in decreased expression of CYP19A1 mRNA, N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CYP19A1 mRNA CTD PMID:15964185 , PMID:16480277 obeticholic acid decreases expression ISO RGD:1606587 6480464 obeticholic acid results in decreased expression of CYP19A1 mRNA CTD PMID:27939613 ochratoxin A increases expression ISO RGD:1606587 6480464 ochratoxin A results in increased expression of CYP19A1 protein CTD PMID:23296098 oleuropein decreases activity ISO RGD:1606587 6480464 oleuropein results in decreased activity of CYP19A1 protein CTD PMID:17910019 Oxadiazon increases activity ISO RGD:1606587 6480464 oxadiazon results in increased activity of CYP19A1 protein CTD PMID:16996190 oxcarbazepine decreases activity ISO RGD:1606587 6480464 oxcarbazepine results in decreased activity of CYP19A1 protein CTD PMID:17959350 oxiconazole decreases activity ISO RGD:1606587 6480464 oxiconazole results in decreased activity of CYP19A1 protein CTD PMID:24496634 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of CYP19A1 mRNA CTD PMID:30599193 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of CYP19A1 mRNA CTD PMID:18636392 p-tert-Amylphenol multiple interactions ISO RGD:737520 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 mRNA, [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 protein CTD PMID:29029336 p-tert-Amylphenol decreases expression ISO RGD:737520 6480464 4-tert-octylphenol results in decreased expression of CYP19A1 mRNA CTD PMID:29029336 paclitaxel increases activity ISO RGD:1606587 6480464 Paclitaxel results in increased activity of CYP19A1 protein CTD PMID:14691014 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP19A1 mRNA CTD PMID:25607892 paracetamol decreases expression ISO RGD:1606587 6480464 Acetaminophen results in decreased expression of CYP19A1 mRNA, Acetaminophen results in decreased expression of CYP19A1 protein CTD PMID:33098425 paracetamol increases expression ISO RGD:1606587 6480464 Acetaminophen results in increased expression of CYP19A1 mRNA CTD PMID:26690555 paracetamol multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP19A1 mRNA CTD PMID:25607892 parathion-methyl increases activity ISO RGD:1606587 6480464 Methyl Parathion results in increased activity of CYP19A1 protein CTD PMID:16996190 paroxetine decreases activity ISO RGD:1606587 6480464 Paroxetine results in decreased activity of CYP19A1 protein CTD PMID:26162595 pasireotide multiple interactions EXP 6480464 pasireotide inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] CTD PMID:23137853 pentachlorophenol decreases expression ISO RGD:1606587 6480464 Pentachlorophenol results in decreased expression of CYP19A1 mRNA CTD PMID:21296122 perflubron increases expression ISO RGD:1606587 6480464 perflubron results in increased expression of CYP19A1 mRNA CTD PMID:25871633 perfluorononanoic acid multiple interactions EXP 6480464 [perfluoro-n-nonanoic acid co-treated with [Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening Agents co-treated with Insecticides co-treated with Fungicides, Industrial co-treated with Herbicides]] results in increased expression of CYP19A1 mRNA CTD PMID:25588985 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1606587 6480464 [bisphenol A co-treated with 2 more ... CTD PMID:25765474 , PMID:34929288 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1606587 6480464 perfluorooctane sulfonic acid results in increased expression of CYP19A1 mRNA CTD PMID:23074026 , PMID:25765474 perfluorooctanoic acid increases activity EXP 6480464 perfluorooctanoic acid results in increased activity of CYP19A1 protein CTD PMID:8812269 perfluorooctanoic acid increases expression ISO RGD:737520 6480464 perfluorooctanoic acid results in increased expression of CYP19A1 mRNA CTD PMID:35104888 perfluorooctanoic acid decreases activity EXP 6480464 perfluorooctanoic acid results in decreased activity of CYP19A1 protein CTD PMID:8812269 phenanthrene increases expression ISO RGD:1606587 6480464 phenanthrene results in increased expression of CYP19A1 protein CTD PMID:28803881 phenanthrene multiple interactions ISO RGD:1606587 6480464 [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein CTD PMID:28803881 phenobarbital multiple interactions ISO RGD:1606587 6480464 Phenobarbital promotes the reaction [Valproic Acid results in decreased activity of CYP19A1 protein] CTD PMID:17959350 phenobarbital decreases activity ISO RGD:1606587 6480464 Phenobarbital results in decreased activity of CYP19A1 protein CTD PMID:17959350 phenytoin decreases activity ISO RGD:1606587 6480464 Phenytoin results in decreased activity of CYP19A1 protein CTD PMID:17959350 PhIP multiple interactions ISO RGD:1606587 6480464 [2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine co-treated with Ethanol] results in increased activity of CYP19A1 protein CTD PMID:32113805 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1606587 6480464 [Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA more ... CTD PMID:16357189 phorbol 13-acetate 12-myristate decreases activity ISO RGD:1606587 6480464 Tetradecanoylphorbol Acetate results in decreased activity of CYP19A1 protein CTD PMID:10338361 pirimicarb increases activity ISO RGD:1606587 6480464 pirimicarb results in increased activity of CYP19A1 protein CTD PMID:11884232 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP19A1 mRNA CTD PMID:19162173 piroxicam multiple interactions ISO RGD:1606587 6480464 Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA] CTD PMID:19147701 piroxicam decreases expression ISO RGD:1606587 6480464 Piroxicam results in decreased expression of CYP19A1 mRNA CTD PMID:15964185 piroxicam decreases activity ISO RGD:1606587 6480464 Piroxicam results in decreased activity of CYP19A1 protein CTD PMID:15964185 plumbagin decreases expression EXP 6480464 plumbagin results in decreased expression of CYP19A1 mRNA CTD PMID:34302802 potassium dichromate multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CYP19A1 protein CTD PMID:33675932 potassium dichromate increases expression ISO RGD:737520 6480464 Potassium Dichromate results in increased expression of CYP19A1 mRNA CTD PMID:23608068 prochloraz multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA CTD PMID:25607892 prochloraz multiple interactions ISO RGD:1606587 6480464 [prochloraz co-treated with Chlorpyrifos co-treated with triflusulfuron-methyl] results in increased expression of CYP19A1 mRNA, [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA CTD PMID:25233012 prochloraz increases expression ISO RGD:1606587 6480464 prochloraz results in increased expression of CYP19A1 mRNA CTD PMID:25233012 , PMID:25765474 prochloraz increases activity ISO RGD:1606587 6480464 prochloraz results in increased activity of CYP19A1 protein CTD PMID:20087668 prochloraz decreases activity ISO RGD:1606587 6480464 prochloraz results in decreased activity of CYP19A1 protein CTD PMID:10806373 more ... procymidone multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA CTD PMID:25607892 profenofos decreases expression EXP 6480464 profenofos results in decreased expression of CYP19A1 mRNA CTD PMID:18828448 progesterone increases activity ISO RGD:1606587 6480464 Progesterone results in increased activity of CYP19A1 protein CTD PMID:15862960 progesterone multiple interactions EXP 6480464 [FSHB protein results in increased expression of CYP19A1 mRNA] which results in increased abundance of Progesterone, IGF1 protein promotes the reaction [[FSHB protein results in increased expression of CYP19A1 mRNA] which results in increased abundance of Progesterone] CTD PMID:22067323 progesterone decreases expression ISO RGD:1606587 6480464 Progesterone results in decreased expression of CYP19A1 mRNA CTD PMID:22130322 propamocarb increases activity ISO RGD:1606587 6480464 propamocarb results in increased activity of CYP19A1 protein CTD PMID:11884232 propazine multiple interactions ISO RGD:1606587 6480464 formestane inhibits the reaction [propazine results in increased activity of CYP19A1 protein] CTD PMID:10746939 propazine increases activity ISO RGD:1606587 6480464 propazine results in increased activity of CYP19A1 protein CTD PMID:10746939 , PMID:11675267 propazine increases expression ISO RGD:1606587 6480464 propazine results in increased expression of CYP19A1 mRNA CTD PMID:10746939 , PMID:11675267 propiconazole decreases activity ISO RGD:1606587 6480464 propiconazole results in decreased activity of CYP19A1 protein CTD PMID:16996190 propiconazole multiple interactions EXP 6480464 [bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion co-treated with terbutylazine] results in increased expression of CYP19A1 mRNA CTD PMID:23954766 propylparaben affects expression ISO RGD:1606587 6480464 propylparaben affects the expression of CYP19A1 mRNA, propylparaben affects the expression of CYP19A1 protein CTD PMID:23744433 propylparaben increases expression ISO RGD:737520 6480464 propylparaben results in increased expression of CYP19A1 protein CTD PMID:34365652 propylparaben increases expression ISO RGD:1606587 6480464 propylparaben results in increased expression of CYP19A1 mRNA, propylparaben results in increased expression of CYP19A1 protein CTD PMID:34365652 prostaglandin E2 multiple interactions ISO RGD:1606587 6480464 2-methoxyoestrone-3-O-sulphamate inhibits the reaction [Dinoprostone results in increased activity of CYP19A1 protein] more ... CTD PMID:15862962 more ... prostaglandin E2 increases activity EXP 6480464 Dinoprostone results in increased activity of CYP19A1 protein CTD PMID:23054057 prostaglandin E2 increases expression ISO RGD:1606587 6480464 Dinoprostone results in increased expression of CYP19A1 mRNA, Dinoprostone results in increased expression of CYP19A1 protein CTD PMID:16024248 more ... prostaglandin E2 increases activity ISO RGD:1606587 6480464 Dinoprostone results in increased activity of CYP19A1 protein CTD PMID:15862962 , PMID:16024248 prostaglandin F2alpha decreases expression ISO RGD:737520 6480464 Dinoprost results in decreased expression of CYP19A1 mRNA CTD PMID:15271885 prostaglandin F2alpha decreases expression EXP 6480464 Dinoprost results in decreased expression of CYP19A1 mRNA, Dinoprost results in decreased expression of CYP19A1 protein CTD PMID:11517196 , PMID:15271885 prostaglandin F2alpha multiple interactions EXP 6480464 Dinoprost promotes the reaction [GATA4 protein binds to CYP19A1 promoter] CTD PMID:15271885 pyrene affects expression ISO RGD:1606587 6480464 pyrene affects the expression of CYP19A1 protein CTD PMID:28803881 pyrene multiple interactions ISO RGD:1606587 6480464 [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein CTD PMID:28803881 quercetin increases expression ISO RGD:1606587 6480464 Quercetin results in increased expression of CYP19A1 mRNA CTD PMID:15319488 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased expression of CYP19A1 mRNA] CTD PMID:32810592 quercetin decreases expression ISO RGD:1606587 6480464 Quercetin results in decreased expression of CYP19A1 mRNA CTD PMID:10704911 more ... quercetin decreases activity ISO RGD:1606587 6480464 Quercetin results in decreased activity of CYP19A1 protein CTD PMID:16023337 , PMID:16965912 quercetin increases activity ISO RGD:1606587 6480464 Quercetin results in increased activity of CYP19A1 protein CTD PMID:15319488 quinalphos increases expression ISO RGD:737520 6480464 quinalphos results in increased expression of CYP19A1 mRNA CTD PMID:34014595 raloxifene decreases expression ISO RGD:1606587 6480464 Raloxifene Hydrochloride results in decreased expression of CYP19A1 mRNA CTD PMID:10704911 raloxifene multiple interactions ISO RGD:1606587 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of CYP19A1 mRNA CTD PMID:19059307 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of CYP19A1 mRNA, resveratrol results in increased expression of CYP19A1 protein CTD PMID:22357324 resveratrol multiple interactions ISO RGD:1606587 6480464 Resveratrol inhibits the reaction [Dinoprostone results in increased expression of CYP19A1 protein] more ... CTD PMID:18462857 , PMID:30409902 resveratrol decreases activity ISO RGD:1606587 6480464 resveratrol analog results in decreased activity of CYP19A1 protein more ... CTD PMID:16611627 more ... resveratrol increases expression ISO RGD:1606587 6480464 resveratrol analog results in increased expression of CYP19A1 mRNA CTD PMID:24610083 resveratrol decreases expression ISO RGD:1606587 6480464 resveratrol results in decreased expression of CYP19A1 mRNA CTD PMID:16611627 , PMID:17766065 rolipram multiple interactions ISO RGD:1606587 6480464 Rolipram inhibits the reaction [Atrazine inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA]] CTD PMID:28859905 rose bengal decreases activity EXP 6480464 Rose Bengal results in decreased activity of CYP19A1 protein CTD PMID:18310892 rotenone decreases activity ISO RGD:1606587 6480464 Rotenone results in decreased activity of CYP19A1 protein CTD PMID:15319488 rottlerin decreases activity ISO RGD:1606587 6480464 rottlerin results in decreased activity of CYP19A1 protein CTD PMID:15955695 rutin increases expression EXP 6480464 Rutin results in increased expression of CYP19A1 protein CTD PMID:29899696 SB-239063 multiple interactions EXP 6480464 SB 239063 inhibits the reaction [bisphenol A results in increased expression of and results in increased activity of CYP19A1 protein] CTD PMID:20096755 SC-58125 decreases expression ISO RGD:1606587 6480464 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in decreased expression of CYP19A1 mRNA CTD PMID:15964185 SC-58125 decreases activity ISO RGD:1606587 6480464 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in decreased activity of CYP19A1 protein CTD PMID:15964185 semicarbazide increases activity EXP 6480464 carbamylhydrazine results in increased activity of CYP19A1 protein CTD PMID:19788891 semicarbazide multiple interactions EXP 6480464 [carbamylhydrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Testosterone metabolite CTD PMID:19788891 serpentine asbestos decreases expression ISO RGD:1606587 6480464 Asbestos, Serpentine results in decreased expression of CYP19A1 mRNA CTD PMID:24160326 sertraline decreases activity ISO RGD:1606587 6480464 Sertraline results in decreased activity of CYP19A1 protein CTD PMID:26162595 silver atom decreases expression EXP 6480464 Silver analog results in decreased expression of CYP19A1 protein, Silver results in decreased expression of CYP19A1 mRNA CTD PMID:27746313 , PMID:28646569 silver(0) decreases expression EXP 6480464 Silver analog results in decreased expression of CYP19A1 protein, Silver results in decreased expression of CYP19A1 mRNA CTD PMID:27746313 , PMID:28646569 simazine multiple interactions ISO RGD:1606587 6480464 formestane inhibits the reaction [Simazine results in increased activity of CYP19A1 protein] CTD PMID:10746939 simazine increases activity ISO RGD:1606587 6480464 Simazine results in increased activity of CYP19A1 protein CTD PMID:10746939 , PMID:11675267 simazine increases expression ISO RGD:1606587 6480464 Simazine results in increased expression of CYP19A1 mRNA CTD PMID:10746939 , PMID:11675267 sodium arsenite multiple interactions ISO RGD:1606587 6480464 [[sodium arsenite results in increased phosphorylation of SRC protein] which results in increased activity of CYP19A1 protein] which results in increased abundance of Estradiol more ... CTD PMID:24068038 , PMID:32197950 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP19A1 mRNA CTD PMID:30557709 sodium arsenite increases expression ISO RGD:737520 6480464 sodium arsenite results in increased expression of CYP19A1 mRNA CTD PMID:17077188 sodium arsenite increases expression ISO RGD:1606587 6480464 sodium arsenite results in increased expression of CYP19A1 mRNA, sodium arsenite results in increased expression of CYP19A1 protein CTD PMID:24068038 , PMID:29301061 sodium fluoride decreases expression ISO RGD:737520 6480464 Sodium Fluoride results in decreased expression of CYP19A1 mRNA CTD PMID:27862939 T-2 toxin decreases expression ISO RGD:1606587 6480464 T-2 Toxin results in decreased expression of CYP19A1 mRNA CTD PMID:22982764 T-2 toxin multiple interactions ISO RGD:1606587 6480464 1-Methyl-3-isobutylxanthine inhibits the reaction [T-2 Toxin inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA]], T-2 Toxin inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] CTD PMID:30951242 tamoxifen increases expression ISO RGD:1606587 6480464 Tamoxifen analog results in increased expression of CYP19A1 mRNA CTD PMID:19549922 tamoxifen decreases expression ISO RGD:1606587 6480464 Tamoxifen results in decreased expression of CYP19A1 mRNA CTD PMID:10704911 , PMID:21296134 tamoxifen multiple interactions ISO RGD:1606587 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of CYP19A1 mRNA more ... CTD PMID:19059307 more ... tebuconazole decreases activity ISO RGD:1606587 6480464 tebuconazole results in decreased activity of CYP19A1 protein CTD PMID:12127262 terbutylazine multiple interactions EXP 6480464 [bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion co-treated with terbutylazine] results in increased expression of CYP19A1 mRNA CTD PMID:23954766 testolactone decreases activity ISO RGD:1606587 6480464 Testolactone results in decreased activity of CYP19A1 protein CTD PMID:16026110 testosterone affects abundance ISO RGD:1606587 6480464 CYP19A1 gene SNP affects the abundance of Testosterone CTD PMID:16949385 testosterone increases expression ISO RGD:1606587 6480464 Testosterone results in increased expression of CYP19A1 mRNA CTD PMID:23523586 testosterone affects metabolic processing ISO RGD:1606587 6480464 CYP19A1 protein affects the metabolism of Testosterone CTD PMID:11751016 more ... testosterone increases expression EXP 6480464 Testosterone results in increased expression of CYP19A1 mRNA, Testosterone results in increased expression of CYP19A1 protein CTD PMID:15525594 , PMID:21273442 testosterone increases metabolic processing EXP 6480464 CYP19A1 protein results in increased metabolism of Testosterone CTD PMID:16569475 , PMID:21259292 testosterone affects metabolic processing EXP 6480464 CYP19A1 protein affects the metabolism of Testosterone CTD PMID:16080194 testosterone decreases expression ISO RGD:737520 6480464 Testosterone results in decreased expression of CYP19A1 mRNA CTD PMID:20600201 testosterone multiple interactions EXP 6480464 [carbamylhydrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Testosterone metabolite more ... CTD PMID:19788891 , PMID:21273442 testosterone multiple interactions ISO RGD:737520 6480464 [FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP19A1 mRNA more ... CTD PMID:16032706 more ... testosterone multiple interactions ISO RGD:1606587 6480464 [Atrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Testosterone more ... CTD PMID:11751016 more ... testosterone enanthate increases expression EXP 6480464 testosterone enanthate results in increased expression of CYP19A1 mRNA CTD PMID:21427060 testosterone enanthate decreases expression EXP 6480464 testosterone enanthate results in decreased expression of CYP19A1 mRNA CTD PMID:21427060 thiacloprid increases activity ISO RGD:1606587 6480464 thiacloprid results in increased activity of CYP19A1 protein CTD PMID:26464060 , PMID:28750898 thiacloprid affects expression ISO RGD:1606587 6480464 thiacloprid affects the expression of CYP19A1 mRNA CTD PMID:29701941 thiacloprid multiple interactions ISO RGD:1606587 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:29701941 thiacloprid increases expression ISO RGD:1606587 6480464 thiacloprid results in increased expression of CYP19A1 mRNA CTD PMID:26464060 thiamethoxam increases expression ISO RGD:1606587 6480464 thiamethoxam results in increased expression of CYP19A1 mRNA CTD PMID:26464060 thiamethoxam increases expression EXP 6480464 Thiamethoxam results in increased expression of CYP19A1 mRNA CTD PMID:34181816 thiamethoxam multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of CYP19A1 mRNA] CTD PMID:34181816 thiamethoxam increases activity ISO RGD:1606587 6480464 thiamethoxam results in increased activity of CYP19A1 protein CTD PMID:26464060 , PMID:28750898 tiagabine decreases activity ISO RGD:1606587 6480464 tiagabine results in decreased activity of CYP19A1 protein CTD PMID:17959350 titanium dioxide increases expression ISO RGD:737520 6480464 titanium dioxide results in increased expression of CYP19A1 mRNA, titanium dioxide results in increased expression of CYP19A1 protein CTD PMID:24241477 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CYP19A1 mRNA CTD PMID:26277626 titanium dioxide multiple interactions ISO RGD:737520 6480464 [titanium dioxide results in increased expression of CYP19A1 mRNA] which results in increased metabolism of Testosterone CTD PMID:24241477 toxaphene decreases activity ISO RGD:1606587 6480464 Toxaphene results in decreased activity of CYP19A1 protein CTD PMID:16996190 triadimefon decreases activity ISO RGD:1606587 6480464 triadimefon results in decreased activity of CYP19A1 protein CTD PMID:10806373 tributylstannane multiple interactions ISO RGD:1606587 6480464 [Tetrachlorodibenzodioxin co-treated with 3 more ... CTD PMID:11522339 more ... tributylstannane decreases expression ISO RGD:1606587 6480464 tributyltin results in decreased expression of CYP19A1 mRNA CTD PMID:29549738 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of CYP19A1 mRNA CTD PMID:29908848 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of CYP19A1 protein CTD PMID:31129395 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of CYP19A1 protein CTD PMID:31129395 tributylstannane increases expression ISO RGD:1606587 6480464 tributyltin results in increased expression of CYP19A1 mRNA, tributyltin results in increased expression of CYP19A1 protein CTD PMID:15941851 more ... tributylstannane decreases activity EXP 6480464 tributyltin results in decreased activity of CYP19A1 protein CTD PMID:18310892 tributylstannane increases activity ISO RGD:1606587 6480464 tributyltin results in increased activity of CYP19A1 protein CTD PMID:16996190 tributylstannane decreases activity ISO RGD:1606587 6480464 tributyltin results in decreased activity of CYP19A1 protein CTD PMID:11522339 , PMID:11751016 Tributyltin oxide decreases activity ISO RGD:1606587 6480464 bis(tri-n-butyltin)oxide results in decreased activity of CYP19A1 protein CTD PMID:17599374 Tributyltin oxide decreases expression ISO RGD:1606587 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CYP19A1 mRNA CTD PMID:28936609 Tributyltin oxide multiple interactions ISO RGD:1606587 6480464 bis(tri-n-butyltin)oxide promotes the reaction [bisphenol A results in decreased activity of CYP19A1 protein] more ... CTD PMID:17599374 triclosan increases expression EXP 6480464 Triclosan results in increased expression of CYP19A1 mRNA CTD PMID:30447264 triclosan multiple interactions EXP 6480464 [Triclosan co-treated with FSHB protein] results in increased expression of CYP19A1 protein CTD PMID:30447264 triflusulfuron-methyl multiple interactions ISO RGD:1606587 6480464 [prochloraz co-treated with Chlorpyrifos co-treated with triflusulfuron-methyl] results in increased expression of CYP19A1 mRNA CTD PMID:25233012 triphenylstannane affects activity EXP 6480464 triphenyltin affects the activity of CYP19A1 protein CTD PMID:20708649 triphenylstannane decreases expression ISO RGD:1606587 6480464 triphenyltin results in decreased expression of CYP19A1 mRNA CTD PMID:29549738 tris(2-butoxyethyl) phosphate increases expression ISO RGD:1606587 6480464 tris(2-butoxyethyl) phosphate results in increased expression of CYP19A1 mRNA CTD PMID:29024780 tris(2-chloroethyl) phosphate increases expression ISO RGD:1606587 6480464 tris(chloroethyl)phosphate results in increased expression of CYP19A1 mRNA CTD PMID:22446829 troglitazone multiple interactions ISO RGD:1606587 6480464 LG 100268 promotes the reaction [troglitazone results in decreased activity of CYP19A1 mRNA] more ... CTD PMID:10814527 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CYP19A1 mRNA CTD PMID:12706301 troglitazone decreases expression ISO RGD:1606587 6480464 troglitazone results in decreased expression of CYP19A1 mRNA CTD PMID:10814527 troglitazone decreases activity ISO RGD:1606587 6480464 troglitazone results in decreased activity of CYP19A1 protein CTD PMID:10814527 trovafloxacin decreases activity ISO RGD:1606587 6480464 trovafloxacin results in decreased activity of CYP19A1 protein CTD PMID:26141389 U-73122 multiple interactions ISO RGD:1606587 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:29701941 urethane decreases expression ISO RGD:1606587 6480464 Urethane results in decreased expression of CYP19A1 mRNA CTD PMID:28818685 valproic acid decreases activity ISO RGD:1606587 6480464 Valproic Acid results in decreased activity of CYP19A1 protein CTD PMID:17959350 valproic acid decreases expression ISO RGD:1606587 6480464 Valproic Acid results in decreased expression of CYP19A1 mRNA CTD PMID:25716160 valproic acid increases expression ISO RGD:1606587 6480464 Valproic Acid results in increased expression of CYP19A1 mRNA CTD PMID:27188386 , PMID:32623605 valproic acid affects expression ISO RGD:1606587 6480464 Valproic Acid affects the expression of CYP19A1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1606587 6480464 CEBPA protein affects the reaction [Valproic Acid results in increased expression of CYP19A1 mRNA] more ... CTD PMID:17959350 more ... vecuronium bromide multiple interactions ISO RGD:1606587 6480464 Vecuronium Bromide inhibits the reaction [Nicotine results in decreased expression of CYP19A1 mRNA], Vecuronium Bromide inhibits the reaction [Nicotine results in decreased expression of CYP19A1 protein] CTD PMID:30959089 vinclozolin multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA more ... CTD PMID:22120136 , PMID:25607892 vinclozolin multiple interactions ISO RGD:1606587 6480464 [vinclozolin co-treated with Atrazine] results in decreased activity of CYP19A1 protein more ... CTD PMID:17599374 vinclozolin increases expression EXP 6480464 vinclozolin metabolite results in increased expression of CYP19A1 mRNA more ... CTD PMID:22285353 more ... vinclozolin increases activity ISO RGD:1606587 6480464 vinclozolin results in increased activity of CYP19A1 protein CTD PMID:12127262 vinclozolin increases expression ISO RGD:1606587 6480464 vinclozolin results in increased expression of CYP19A1 mRNA CTD PMID:12127262 vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of CYP19A1 mRNA CTD PMID:15084515 vitamin E multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of CYP19A1 mRNA] CTD PMID:32810592 vorozole affects binding ISO RGD:1606587 6480464 vorozole analog binds to CYP19A1 protein CTD PMID:9720668 zearalenone decreases activity ISO RGD:1606587 6480464 Zearalenone results in decreased activity of CYP19A1 protein CTD PMID:16023337 , PMID:36374910 zearalenone decreases expression ISO RGD:737520 6480464 Zearalenone results in decreased expression of CYP19A1 mRNA, Zearalenone results in decreased expression of CYP19A1 protein CTD PMID:29758222
